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It is now well accepted by gynecologists that a woman can conceive from an act of 
intercourse for a maximum of seven days of her menstrual cycle [l]. The reliability of 
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natural family planning methods depends on identifying this window of fertility without 
ambiguity. Several natural family planning (NFP) methods have been used extensively 
and with some success. For decades, cycle length and BBT history have been used to 
forecast the most likely days of ovulation. When greater precision is needed, serum LH 
assays or ultrasound techniques are used. With the recent development of enzyme-linked 
immunosorbent assay, various kits have become commercially available to provide a 
simple, self-administered, and rapid test for detection of the midcycle urinary LH surge 
[2]. Some of these methods are fairly reliable and accurate. However, failures in these 
methods still occur, and some other problems concerning accuracy, simplicity, cost, and 
comfort have not been solved yet [3]. In addition, other factors in NFP methods, such as 
the user, the procedure, and others, have been demonstrated to be important sources of 
errors. 
The prototype system developed in this thesis, called the OVULO-COMPUTER 
(QC), deals with these unsolved issues by integrating the most well accepted methods of 
family planning in a computer-knowledge-base system capable of acquiring, manipulat-
ing, storing, and displaying data in real-time. In addition to monitoring ovulation, the OC 
also automates the process of rule comparison and evaluation by providing the physicians 
with results from different rules applied to the same set of data. The system consists of 
an IBM compatible, 286 or 386 microcomputer, an 8-channel analog-to-digital converter, 
an J/O interface program, and a main central program written in Lotus 1-2-3 Command 
Language. The software operates under MS-DOS operating system. New features of the 
1-2-3 Release 3.1 allow improved user interface capabilities, as well as enhanced graph-
ics presentation. The OC is a user-friendly system designed to help doctors and nurses 
make easier and more accurate clinical decisions in the analysis and interpretation of the 
fertility status in women. 
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CHAPTER I 
INTRODUCTION 
Simple and reliable methods for predicting and confirming ovulation have been long 
desired by physicians and infertility patients. The main goals of such methods seek to 
provide great accuracy in the management of infertility as well as in the reliability of 
birth control methods. 
Various health and research groups are searching for new ways to improve current 
methods of prediction and determination of ovulation and to develop new ones. Natural 
family planning programs search to improve the reliability of methods for defining the 
fertile period of the menstrual cycle and to extend their utility to periods of lactation, 
onset of menarche, and the approach of menopause. Artificial insemination and in vitro 
fertilization programs look for more complete information on the timing of ovulation and 
the period of optimum fertility to maximize the chances of conception while minimizing 
the cost and inconvenience of preliminary testing [ 4]. 
Ovulation itself cannot be observed externally. The only definite proof of its 
occurrence is establishment of pregnancy, which is normally the outcome being regu-
lated. Therefore, it becomes necessary to predict the timing of ovulation on the basis of 
indirect physiological indicators which vary consistently with the time of ovulation [4]. 
As shown in Figure l, the chances of conception from an act of intercourse are very 
low 6 days before ovulation, increase to a maximum during the day before ovulation, and 
fall to zero within 24 hours after ovulation [1]. 
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Fi!filre 1. Probability of conception vs. the time of intercourse relative to 
ovu ation in the human [ 1]. 
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The scientific challenge then is to devise methods for identifying these periods of 
fertility and infertility with absolute certainty so that couples who use natural family 
planning have the same reliability as those using other modem family planning 
methods[l]. Brown et. al, states that the main difficulty in natural family planning for 
motivated couples is not the periodic abstinence required, which may in fact enrich the 
union. Rather, it is uncertainty in defining the fertile phase accurately, the excessive 
abstinence that is therefore required for maintaining adequate safety margins, and the 
loss of confidence resulting from unexplained pregnancies [1]. 
For decades it has been relatively easy to make the retrospective diagnosis of ovula-
tion and even determine its approximate occurrence time. The events preceding ovulation 
are not always easy to monitor symptomatically and are extremely variable among 
women [5]. 
The prospective diagnosis of ovulation, however, is a problem that currently is 
without satisfactory solution. According to Kenigsberg, no method can achieve 100% 
confidence of prospective ovulation within 24 hours in the natural ovulation cycle. He 
3 
adds, however, that the combination of some of the current reliable techniques will 
increase considerably the accuracy of new fertility monitors [5]. 
There have been many attempts to solve these needs. For over two decades, scien-
tists have increased the research in this field. Important studies made in this field are dis-
cussed in the next chapter. Chapter 3 describes some home-use kits that have been pro-
posed, some for detection only, and others for both detection and prediction of the ovula-
tion timing. Also, more sophisticated devices, such as the ones based on ultrasound or 
hormone-based techniques, have been considered for years. Each of these devices has 
been based strictly on measuring only one parameter to make conclusions about what the 
ovulation conditions are. However, few satisfactory results have been obtained so far, 
and there are still several unsolved issues concerning accuracy, reliability, comfort, and 
cost. 
MOTIVATION 
The OVULO-COMPUTER concept emerged in response to several motivations in 
the field of fertility assessment. 
A Renewed Interest in Natural Family Planning 
More and more women are rejecting artificial methods of family planning and look-
ing for reliable and easy-to-use natural methods. Artificial methods are not accepted by 
couples some because of ethical, religious, philosophical, health, and esthetic reasons. 
Therefore, methods to determine the fertile and infertile phases of the menstrual cycle 
can be used by couples as a contraceptive aid. They may appeal to people who wish to 
practice natural family planning, which implies abstinence from sexual intercourse dur-
ing the fertile days of the menstrual cycle, or who wish to limit the use of barrier methods 
or coitus interruptions to the days of the menstrual cycle during which sexual intercourse 
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can result in pregnancy [6]. 
Safety Concerns and Side Effects of Contraceptives 
Closely related to the first motivation, extensive studies have shown that contracep-
tive methods, though so far more reliable than NFP methods, present many side effects 
that have become determinant for the couple when selecting which birth control method 
they decide to use. Side effects can range from mild to potentially life threatening. Some 
of the well known are: cordiovascular complications, pelvic inflammatory diseases, vagi-
nal infections, and infertility. All these drawbacks encourage family planning programs 
to look for better methods that may lead to disregard of contraceptives or at least to 
reduce the use of them [7]. 
Artificial Insemination and Special Treatments in Infertile Couples 
For several years, scientists have been doing research in an attempt to find the 
causes of infertility in couples. Their goal has been to develop special techniques to find 
the period of optimum fertility for conception. The success of some therapeutic meas-
ures, such as artificial insemination, depends upon adequate documentation and timing of 
ovulation. When pregnancy is desired by both fertile and sub-fertile couples, a fertility 
indicator can be used for timing intercourse to maximize the chance of conception, as 
well as for monitoring the administration and effects of therapy in infertile couples. 
Quality Patient Care and Traditional Methods 
Knowledge of a patient's past medical history is a critical factor in the delivery of 
quality patient care. In the event that patient information is unavailable, insufficient, or 
inaccurate at the time of assessment, as is frequently the case, the next line of inquiry is 
the patient's medical record. The traditional paper-based charting system used in record-
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ing menstrual cycle data has inherent limitations. The physical chart may be unavailable 
due to temporary mislocation or possession by other users who are reviewing or record-
ing data. Even when the chart is available, poor organization, illegible handwriting and 
sheer volume may make retrieval of clinically significant information time-consuming, 
laborious, and incomplete [8]. 
Need of Tools for Comparison and Evaluation 
Tools to compare and evaluate methods for the prediction and detection of the ovu-
lation timing have been desired for decades. Diversity in the interpretation of rules has 
been of great concern to many researchers [9]. Most physicians agree that the best refer-
ence tool to confirm ovulation is the LH serum technique. The sustained rise in the 
woman's basal body temperature (BBT) is a well documented confirmation of ovulation. 
Evaluation of these rules has frequently resulted in contradiction among research results 
[9, 10, 11]. Therefore, the implementation of a tool such as a computer based system for 
objective and reliable evaluations would be greatly appreciated by gynecologists, 
researchers, and practitioners in the field of fertility. This tool may also have a great 
impact in deciding which family planning method is more reliable and accurate. 
OVERVIEW OF THE SYSTEM 
In response to such a great need for a comprehensive, accurate, flexible, and reliable 
device for the prediction and detection of ovulation in women, a computerized system for 
measuring, visualizing, and interpreting relevant changes in the woman's body is pro-
posed in this thesis. The main goals of this thesis are: 
• Design a computer-based system for evaluation and comparison of rules concern-
ing the ovulation in women. 
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• Develop a more comprehensive fertility monitor based on more than one parameter. 
• Eliminate some sources of human errors by automating some procedures in the col-
lection and interpretation of data. 
The major features of this system consist of acquiring, measuring, and interpreting 
different types of bio-physical variables involved in women's menstrual cycles, espe-
cially around the ovulation day. By integrating hardware and software technologies, this 
system automates as much as possible the tedious tasks of data gathering and interpreta-
tion. Decision making is enhanced by providing accurate data about the ovulation status; 
however, physicians, nurses, or practitioners will evaluate the most prudent course of 
action. 
As mentioned before, methods of gathering and recording data concerning ovulation 
present limitations. By interfacing the sensors directly to the electronic monitoring sys-
tem, the OC automatically records the patient data, eliminating the burden and errors of 
manual procedures. The system acquires real-time patient data from a number of bio-
physical electrodes. This system is also able to accept data manually from the user (e.g. 
symptoms), from any other physiological monitoring equipment, or from other medical 
departments, such as ultrasound or assay laboratories. 
In order to facilitate the review, comparison, evaluation, and interpretation of the 
data, the OC provides the following features. 
• Graphics: Graphical trends are provided on either a video display or a dot-matrix or 
laser printer. 
• Charts: A summary chart displays the results after the rules have been applied to the 
data. The table-like features of the 1-2-3 spreadsheet allow the user to visualize 
numerical and text variables on the screen or at the printer. 
• Decisions: Based on the most generally accepted rules, the OC evaluates each of 
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rules to a specific set of data and provides the user a diagnosis of the fertility status. 
Some of the rules provide also a probability of the results calculated. 
All of these features enhance the usefulness of the system and allow the user to 
draw more accurate conclusions from absolute values, trends, or inferred values 
from combinations of many parameters. 
The OC could be considered as a research support tool in the prediction and detec-
tion of ovulation, and for comparison and evaluation of rules to determine the fertile and 
infertile phases of the woman's menstrual cycle. Although this system has been designed 
exclusively for clinic and hospital use, there is also a future goal to build a simple, easy-
to-use device based on the results of this system for the consumer. 
CHAPTER II 
BIOPHYSICAL PHENOMENA AND ELECTROPHYSICAL MEASUREMENTS 
INTRODUCTION 
Overview on the Menstrual Cycle 
Unlike male fertility, which is relatively constant, female fertility is cyclic; ovula-
tion normally occurs once a month and is regulated by a hormone system that involves 
the hypothalamus, pituitary gland, and ovaries. Understanding how these hormone pat-
terns affect the maturation and release of an egg from the ovary, and uterine preparation 
for implantation, is fundamental to understanding how natural family planning methods 
work [12]. 
The menstrual cycle needs to be distinguished from the menstrual period. A 
woman's menstrual cycle begins with the first day of her menstrual flow and last through 
the day before before the next menstrual flow starts. The menstrual period is the time of 
menstrual flow, usually lasting 3 to 7 days [12]. 
Cycle phases are traditionally named either by the changes that occur in the ovary 
(the follicular phase and the luteal phase) or by the changes that occur in the lining of the 
uterus (the menstrual phase, the proliferative phase, and the secretory phase). The first 
day of menstrual flow, by convention, is called day 1 of the menstrual cycle. The time 
interval between ovulation and the onset of menstruation is consistently close to 14 days 
for all women (normal range 12 to 17 days) [12]. 
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A woman is most likely to conceive if fresh sperm are present in the reproductive 
tract when ovulation occurs. The woman's oocyte retains maximal potential for fertiliza-
tion for 12 to 24 hours. Sperm retain potential for fertility for a significantly longer inter-
val, 100 hours or more. Intercourse during the 4 days preceding ovulation results in the 
highest conception rates during a menstrual cycle [12]. 
Charting 
Menstrual cycle charting is based on observations of the physiologic changes during 
the cycle. The actual charting carries the observation one step further, to precise docu-
mentation of the changes. Charting is a method for planning or preventing pregnancies 
by identifying the fertile days of a woman's menstrual cycle. It is not, therefore, a 
method of contraception. Instead, the user must rely on abstinence or other contracep-
tives during her fertile days. Moreover, many women rely on charting methods as a 
means for conceiving [12]. 
When charting is combined with other methods of family planning during the fertile 
period, it is called fertility awareness. When charting is used for birth control in combi-
nation with abstinence during the fertile period, it is called natural family planning, and 
includes the rhythm or the calendar method, the basal body temperature method, the ovu-
lation or Billings method, and the sympto-thermal method [12]. 
METHODS OF MONITORING AND PREDICTING OVULATION 
In this section an overview of some of the most recent and well accepted methods 
will be given. Special emphasis has been given to selected methods based on their 
relevance as well as on the parameters that can be electrically measured and adapted to 
a computer system. 
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Electrical Resistance Method 
Salivary and cervicovaginal changes in electrolyte content through the menstrual 
cycle have been described for decades [13, 14, 15]. During the last few years, several stu-
dies have been made in an effort to understand these changes. The most significant work 
on this technique was done by Albrecht et. al in 1985 [16]. Since then, many other inves-
tigators have evaluated and proved the importance of this work. Albrecht found that 
mean changes in the Vaginal Electrical Resistance (VER) indicate a clearly defined nadir 
on the day of the LH peak. The VER mean at LH peak day was significantly lower than 
the overall mean for all other days. Thus, the absolute value of VER, combined with the 
rapid decline in the last three days before this nadir, are interpreted as a sign of imminent 
ovulation. The most significant change in VER was on the day after the LH peak, when 
the mean VER was 70% higher than on the previous day. This change coincided with the 
day of ovulation, which in most cases, is assumed to occur within 24 hours of the LH 
peak [16]. 
In this same study, Albrecht found that changes in the salivary electrical resistance 
(SER) also followed a predictable pattern during the preovulatory phase. A peak SER 
value was consistently seen 5 to 6 days before the cycle day of the LH surge. After the 
SER peak, SER values remain low for 3 days and increase again before ovulation. This 
SER peak, therefore, could be used to predict the day of ovulation. 
The physiological causes of these changes have also been explained. The changes 
in VER, Albrecht states, are primarily caused by changes in the ionic content of the cerv-
ical mucus and its volume. SER changes which are consistent with changes in sodium 
concentration are thought to be related to the effect of estrogen on the renin-angiotensin 
system [16]. The physiologic basis for the nadir in VER during the periovulatory days is 
justified because of the well known properties of cervical and vaginal mucus secretion 
during those days. The increase in volume and ferning of the mucus are at a maximum 
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coincident with the preovulatory estrogen peak. Feming is due to NaCl crystal formation 
in the presence of mucin; the 10- to 12-fold increase in volume of that mucus should pro-
vide a high conductance and therefore, a low electrical resistance [15]. 
Most of these studies have confirmed the usefulness and consistency of these 
salivary and vaginal changes [5, 11, 16, 17, 18]. However, because these methods were 
developed recently, more studies are needed to establish the reliability for some cases, 
such as in women with variable cycle lengths, or when abnormal vaginal secretions or 
infections are presented [15]. Some studies have questioned the usefulness of VER and 
SER techniques [19, 20]. However, the differences in the results obtained were probably 
due to differences in the device calibration and the product used (The Peak Monitor). 
SER and VER method has also proven to be reliable when used in cycles where 
clomiphene citrate was used to induce ovulation. A protocol for timing inseminations 
developed by Fernando et. al showed that inseminations based on the SER peak would 
have been timed within 24 hours of the thermal nadir in 14 of 15 cycles [18]. In another 
study, Fazleabas adds that combining the prediction capability of the SER peak with the 
more precise indication of ovulation provided by the VER trend could result in accurate 
timing of the inseminations. Thus the convenience of advance scheduling is made 
without sacrificing accuracy. Also, this method would avoid performing multiple insemi-
nations as required by other methods. 
Tests Based on Hormone Assays 
Useful hormonal determinations include daily assays of serum or urinary LH, uri-
nary estrogens (or estrogen metabolites) or serum estradiol, and serum progesterone or 
urinary pregnanediol [11]. 
LH Assays. The rapidity of the LH surge requires frequent sampling. Unless urin.e 
is used, this presently involves repeated venipuncture. Still, it often cannot be used 
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effectively for frequent serial sampling because of problems with trauma, infection, and 
red cell depletion [ 4]. 
Radioirnrnunoassay (RIA) of LH is now readily available in most hospitals and 
through commercial laboratories. Daily assay of serum LH in midcycle can detect the 
LH surge, which is presumed to occur before actual ovulation. The temporal relationship 
of the LH surge and ovulation has been studied by several investigators [11]. According 
to Campbell, assays for progestogens in serum, saliva, and urine meet high standards 
with respect to accuracy, bias, and sensitivity, as do assays for estrogens in serum [4]. 
Estrogen Assays. Serum estradiol demonstrates a characteristic peak approximately 
1 day before the LH surge and 37 hours before ovulation. Serial determinations of serum 
E2 at midcycle, thus, can detect the time of ovulation with a fair amount of accuracy. 
Rapid RIAs for serum E2 are available but require a specialized laboratory and are time-
consuming and expensive. Urinary estrogen assays have been applied for detection and 
timing of ovulation. The preovulatory peak of urinary estrogens ranges between 40 and 
100 micrograms/24 hours. The mean interval between the first observable rise and the 
estrogen peak is 5.5 days. The day after the estrogen peak (day of the LH surge) is 
believed to be the day of maximal fertility [11]. 
Urinary LH Analysis. Urine collection is considered to be easier than serum collec-
tion, however, it may be socially unacceptable in some cultures. The problem can be 
exacerbated by any requirements to accumulate and store urine specimens either for 24 
hour periods or as serial samples. Use of short-term, spot, or early morning urines will 
help. The best approach may be the use of self-tests that do not require supervision or 
storage and thereby minimize any embarrassment or inconvenience [4]. 
In a recent study, Kenigsberg reported that monoclonal antibody technology along 
with enzyme-linked imrnunosorbent assay (ELISA) methods have renewed interest in 
urinary hormone assays where both the body fluid and technical skills are readily 
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available to the patient [5]. The basic technology used in these kits involves combined 
monoclonal antibodies to LH coupled with a second antibody reaction resulting in an 
enzyme activation producing a color reaction (usually blue). Depending on the amount 
of reagents, the reaction can be triggered at a certain level of LH (usually 40 mIU and 20 
mIU) to give an "all or none" and an "in between" response, respectively, readable by the 
naked eye. Kenigsberg added that with simultaneous collections of serum and urine, 
correlation between radioimmunoassay (RIA) results in serum and ELISA results in urine 
is virtually 100% [5]. 
Clinical Potentials of the Cervical Mucus Constituents 
Cervical mucus functions have not been totally explained [21]. It presents, except 
at midcycle, a mechanical barrier to particulate (including sperm) that might otherwise 
reach the uterine cavity. A major function of cervical mucus is antimicrobial activity 
which is accomplished by the presence of leukocytes, which are decreased at midcycle, 
and by other inhibiting substances which are not decreased at midcycle and effect micro-
bial inhibition throughout the cycle [21]. 
The pH of the cervical mucus and endocervical canal is important in relation to fer-
tility, since sperm motility is reduced when the pH falls below 6.5. Infertile patients are 
more likely to conceive if the pH is alkaline, and changes in the pH have been noted in 
women taking an oral contraceptive [22]. Spermatozoa are highly susceptible to changes 
in the pH cervical mucus and maintain their activity best in a pH of 7 to 8.5. This is the 
pH range of normal midcycle cervical mucus [23]. There are, however, conflicting 
reports in the literature about the normal range for endocervical pH and whether the 
degree of acidity or alkalinity is under ovarian control [22]. According to Fordney-
Settlage, similar problems exist for the glucose fertility tester and indicine tests. He adds 
that the chief problem with these techniques is the lack of regular predictable changes 
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early enough prior to ovulation [21]. 
Ultrasound Method 
Ultrasound has been used extensively during the past decade to monitor follicular 
growth and to time ovulation in spontaneous as well as stimulated cycles [17]. Follicles 
are imaged as areas having ultrasound density identical to the adjacent full bladder but 
contrasting with surrounding, less dense ovarian tissue. Objects of 5-10 mm are clearly 
discernible to ±lmm. Ultrasound is capable of detecting growing follicles as early as the 
first 5 days of the menstrual cycle. It can register the presence of pre-ovulatory follicles 
of at least 15 mm diameter at 2-3 days prior to ovulation, and can sometimes indicate the 
presence of a detached, ripe ovum/cumulus complex within a Graafian follicle approxi-
mately 16-24 hours prior to ovulation. Although ultrasound serves as an excellent index 
of imminent ovulation, several reports indicate that there is a rather wide range of follicu-
lar sizes (17-27 mm) from which mature, fertilizable eggs may be aspirated. This varia-
bility in attained size and attendant steroid content limits the predictive precision of 
ultrasound. However, since it can detect the collapse of the antrum following ovulation, 
ultrasound has an internal retrospective check on the accuracy of its own predictions [ 4]. 
The advantage of this method is that it is noninvasive and the evidence it provides is 
persuasive. It does require frequent clinic visits and a large investment in equipment, and 
thus it is expensive. Nevertheless, its documentation of ovulation is most reliable in 
retrospect, that is, when follicle collapse or a reduction in follicle size is seen to have 
occurred. For these reasons, this method can not be used for routine ovulation prediction 
[17]. 
According to Campbell, ultrasound must be done serially if accurate information is 
to be obtained. He adds that, until the beginning of the fertile period, even serial ultra-
sonic scans cannot distinguish which of the remaining 4-6 growing follicles will be 
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atretic and which will eventually ovulate [4]. In a more recent study, however, Vermesh 
et. al [2] demonstrated that ovulation was detected by transvaginal ultrasound in all 
cycles, which renders this method an excellent tool for positive confirmation of ovula-
tion. He adds that the advantage of ultrasound over other methods used for retrospective 
detection of ovulation (i.e., serum P and BBT) is that it can pinpoint the day of ovulation 
and not merely the fact that ovulation has occurred. In addition, serial ultrasound exami-
nations provide valuable information about the progressive growth and development of 
the follicle(s). In this study, transvaginal ultrasound was used. This method has been 
shown to have a greater resolution than the classical transvesical route of scanning, espe-
cially when patients are obese or have pelvic adhesions [2]. 
Basal Body Temperature (BBT) 
It has been noted for more than 80 years that there are body temperature changes 
throughout the menstrual cycle. The charting of daily thermometer readings has been 
practiced for more than 40 years [5]. BBT charting has long been a valuable tool for 
detecting the postovulatory phase of the menstrual cycle and as a simple aid for diagnos-
ing ovulation in women who have had difficulty conceiving. The clinical usefulness of 
charts produced by women monitoring their BBT has been limited, for the most part, by 
fragile mercury thermometers requiring three to five minutes to register an accurate tem-
perature, and by the inaccuracy of the charting process when left to the patient. The tem-
perature may be read or recorded incorrectly, or forgotten, or may be taken at times other 
than before rising in the morning. Also, among physicians there exists some sense of 
frustration over the lack of usefulness and interpretation of the BBT graph. One of the 
reasons is the lack of any generally accepted criteria for objectively interpreting BBT 
graphs [24]. 
The term "basal" means the body temperature at rest, unaffected by any activity. It 
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is called the "waking temperature", because it is taken immediately upon waking from 
rest. 
A fertile woman who takes her waking temperature daily under the same conditions 
will notice a biphasic pattern during her cycle. "Biphasic" means it has two levels. First, 
a lower level from menstruation until about the time of ovulation; then, a rise to a higher 
level where it stays until the end of the cycle. Ovulation occurs within a few days before 
or after the rise to an overall higher level. The temperature rise indicates when the post-
ovulatory infertile time is beginning and confinns that the bleeding 1-2 weeks later is 
really menstruation. Women are able to know if pregnancy has occurred once the tem-
perature is high for 18-20 days [12]. 
BBT rises 0.2-0.5 °C (0.4-1.0 °F) due to the midcycle increase in progesterone 
caused by the transformation of the ovarian follicle to the corpus luteum in response to 
the LH surge. Although progesterone begins to rise about 24 hours after the beginning of 
the LH surge or 8 hours before ovulation, the rise from the hypothermic plane existing 
during the follicular phase to the hyperthermic plane present during the luteal phase can 
be observed only an average of 1 day after ovulation. Moreover, since temperature shifts 
also occur in response to other agents, the menstrual cycle shift may be verified by a con-
tinuation of the elevated temperatures for at least 3 days. Therefore, being strictly retros-
pective, BBT cannot predict ovulation: It can only detect probable ovulation and can 
only predict the end of the fertile period [ 4]. 
BBT charts could serve as a "low-tech", inexpensive, and reliable way for docu-
menting ovulatory cycles once they have occurred. They roughly show 10-14 day luteal 
phases in women with cycles with variable lengths. Used in the context of a fertile cou-
ple attempting pregnancy or even for timing at donor insemination, they are useful 
adjuncts. Because of the intrinsic variability of cycle-to-cycle oocyte release and the 
confounding factors affecting measurement (illness, activity, drugs), however, the BBT is 
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not adequate for precise, prospective ovulation prediction [5]. 
Sialic Acid Method 
Sialic acid (N-acetylneuraminic acid) is a normal constituent of body mucins. 
According to Calamera, sialic acid in cervical mucus shows cyclic variations [25]. The 
cervical mucus shares many common properties with other body mucins. Sialic acid 
content in cervical mucus decreases during the follicular phase preceding ovulation, and 
it increases significantly during the luteal phase and pregnancy. Salivary sialic acid 
shows a higher concentration during the follicular phase until 4 or 5 days before the LH 
surge, when a peak of maximal activity is observed. Then, there is a progressive diminu-
tion towards the time of ovulation, followed by a less evident increase. In this study, 
Calamera concluded that their results indicated that saliva sialic acid determinations are 
easy and inexpensive means of studying the menstrual cycle [25]. So far, no commercial 
device has been developed based on this technique. 
PERIODIC ABSTINENCE METHOD 
Sexual abstinence is considered to be the safest method of family planning, 
although not the most practical one. There are some factors that interfere with the effec-
tiveness and practicality of this approach to family planning. First and foremost is irre-
gularity of the menstrual cycle among women and even in the same woman over an 
extended period of time. If all women had regular cycles, calendar rhythm would be a 
reliable contraceptive method. Occasional anovulatory cycles, however, occur even in 
women who are known to have regular cycles and are seen with greater frequency in 
postpubertal and perimenopausal women (11]. 
The effectiveness of periodic abstinence depends largely on the strength of a 
couple's motivation to avoid pregnancy and the woman's ability to interpret signs and 
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symptoms of the fertile period. A major problem has been the unwillingness of one 
partner or the other, usually the male, to agree to long periods of abstinence. Another 
problem is that women sometimes have difficulty in identifying their fertile periods, 
especially if they are breast-feeding, have vaginal or other infections, or are approaching 
menopause [26]. 
Moghissi concluded that a simple, objective, self-administered technique of ovula-
tion prediction, such as a kit for home use will undoubtedly improve the efficacy and 
acceptability of periodic abstinence as a method of family planning [11]. 
Among many possible techniques of natural family planning, the following three 
have been subjected to clinical trials and deserve emphasis. 
Calendar Method (Ogino-Knaus). 
This method identifies the time of ovulation from data recorded over the previous 6 
to 12 months to determine the intervals between menses. The range of possible ovulation 
dates and an additional 3 to 4 days before and after these dates dictate the period of sex-
ual abstinence. Although the length of the normal luteal phase is believed to be rela-
tively constant (14 ± 2 days), irregularities of the menstrual cycle are a frequent source of 
error, and the method has been associated with failure rates ranging from 14.4 to 47 preg-
nancies/100 woman-years (11]. A recent device called L-Sophia bases its principles of 
calculation of the periodic abstinence on this method and BBT (27]. 
Cervical Mucus (Ovulation) Method 
This method relies upon a sign, the discharge of cervical mucus, which is essential 
to human fertility. The menstrual cycle begins with the first day of menstruation and 
ends the day before the beginning of the next menstruation. The menstrual flow lasts 
from 3 to 7 days. Then, five phases of the cervical mucus pattern are recognized: phase 1, 
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dry days; phase 2, early preovulatory days; phase 3, wet days; phase 4, postovulatory 
days; and phase 5, late postovulatory phase [11]. 
The fertile, or unsafe, period is presumed to start on the 1st day in which postmen-
strual mucus is observed (phase 2) and to continue until the fourth day after the clear 
lubricative cervical mucus (peak day) appears, a period that can last from 7 to 14 days. 
All subsequent days are considered infertile and safe for intercourse. A period of formal 
indoctrination is believed to be essential for the successful practice of this technique [ 11]. 
A more detailed explanation to this method is found in Appendix A. Billings et. al and 
Weissman et. al have claimed a high degree of effectiveness in well-motivated couples 
who have been adequately trained [11]. 
Sympto-Thermic Method (STM) 
This method employs not only observation of cervical mucus but also a calendar 
calculation during the preovulatory phase and the BBT shift during the postovulatory 
phase of the menstrual cycle to determine the time of fertility. The calendar calculation 
(21 is subtracted from the shortest cycle length in the preceding 6 months) establishes the 
last day on which sexual relations are permitted during the preovulatory phase. 
Abstinence begins before this day if mucus in noted. Abstinence continues until the third 
day of the BBT rise. After that day, sexual relations may be resumed until the onset of 
menses [11]. 
According to Moghissi, this method is probably the most reliable method of 
periodic abstinence. Provided that the couples are well-motivated, disciplined, and fol-
low the technique closely, a pregnancy rate of less than 1/100 woman-years (Pearl index) 
as reported by Roetzer may be expected. In randomized prospective studies a pregnancy 
rate of 9.4% (Pearl index) was observed among STM users during the year following 
formal entry into the study [11]. 
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There are several symptoms or body signs that reflect hormonal changes in the men-
strual cycle [12]. These signs play an important role and it can be helpful to record them 
because they can provide confirmation to other more accurate signs (e.g. SER, VER). 
Most of these signs constitute the basis of the Sympto-Thermal Method. Some of these 
symptoms considered in the STM are: 
Tissue-Paper Exam of the Cervical Mucus. An important sign observed in NFP is 
the cervical mucus symptom. Fertile women notice a cervical mucus discharge at the 
vaginal entrance during part of their cycle. This is a normal occurrence. Cervical mucus 
is important for fertility. The start of the mucus flow means that a follicle is maturing 
toward ovulation. The possibly fertile time of the cycle has begun. 
In a typical cycle the mucus is at first sticky and cloudy, then progresses to a 
stretchy, clear, lubricative condition like raw egg-white, before changing back to sticky 
or dry about the time of the temperature rise. There may be dry days after menses and 
during the established high-temperature phase [12]. 
Vaginal Sensations. Another important examination is the awareness of vaginal sen-
sations. What women feel through this attentive awareness is as important as what they 
see by doing the tissue exam. The three types of sensations are [12]: 
Sensation-dry: may be a positively dry, somewhat disagreeable, slightly itchy feeling, or 
just a feeling of "nothing". 
Moistness: a feeling of "something" as if secreting moisture or something flowing Down 
inside the vagina or small bubbles bursting inside the vagina. 
Lubrication: a feeling of slipperiness at the vaginal entrance, or a very distinctly runny-
wet feeling, both due to highly-fertile egg-white mucus (EW-M). 
For the purposes of interpretation sensation-dry, moistness and lubrication are 
equivalent to tissue-dry, sticky mucus and EW-M respectively. The peak day is the final 
day of EW-M; that is the final day on which any trait of EW-M is still noticed, namely 
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clear, or stretchy an inch or more, or lubricative, causing the tissue to glide or a slippery-
wet feeling at the vaginal entrance [12]. 
Cervix Signs. Internal cervical exam have been found very helpful for identifying 
fertility. There are basically two observations: 
• Noticing cervical mucus changes by touching the cervix. 
• Noticing mucus at the cervical os (mouth of the cervix) by compressing the cervix. 
The cervix typically changes according to the following cycle pattern: The cervix 
becomes firm, low, closed, and dry during the Relativy Infertile Time. Then, it becomes 
soft, high, open, and wet during the Possibly Fertile Time; and changes back to firm, low, 
closed, and dry during the Completely Infertile Time [12]. 
When compressing the cervix to identify the start of mucus at the cervix in the 
beginning of the cycle, two types of observations are identified in the test [12]: 
Cervix-dry. This sign means no mucus is obtainable by compressing the cervix, or else 
there is at most only a continuous thick yellow or white mucus, which is not cervical. 
Cevix-Wet means cervical mucus is now present that will draw threads, whereas before 
there was none. During the highly fertile time typically "cascades" from the cervix. 
Secondary Signs. Other useful signs for the detection of the days around the ovula-
tion day are [12]: 
lntermenstrual Pain is thought to be related to the fallopian tubes rising up around the 
ovaries near the time of ovulation. This sign is felt as a sharp pain or as a crampiness, 
somewhat like the onset of mild labor contractions. It is usually noticed only for a few 
hours, and rarely for more than two days. Intermenstrual pain, as defined here, seems to 
be associated with peaking estrogen [12]. 
Breast Tenderness may begin with a prickly, tingling sensation, sometimes a sharp pain 
in the breast, more toward the nipple; some women describe it as "having sore nipples". 
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This may change into a heaviness deeper in the breast tissue and can be experienced as 
breast "tension" or "fullness", and finally as tender "lumpiness" just before menses. 
Breast tenderness reflects rising and elevated progesterone levels [12]. 
Intermenstrual Bleeding may be noticed around peak day. It is believed that most 
women have at least microscopic ovulation spotting, but only some that can be observed 
by the naked eye. Intermenstrual bleeding may be noticed as red, blown, pink or yellow-
ish strands in the mucus, or as full bleeding around the time of ovulation, apparently due 
to a sudden drop in estrogen [12]. 
Bleeding other than menstrual period can be pathological bleeding, implantation 
spotting, breakthrough bleeding from excess or prolonged estrogen stimulation, or can 
occur whenever there are erratic fluctuations in the hormones upon which the uterine lin-
ing depends for its support. In particular, since the rebuilding of the uterine lining each 
cycle depends on estrogen, "withdrawal" bleeding can occur whenever there is a drop in 
estrogen (at ovulation time, for instance) [12]. 
Ordinarily, women can distinguish menstruation (menses) easily, however, some-
times there can be confusion. If there is doubt, those women who are charting tempera-
ture know that the only bleeding which is true menstruations is the bleeding that comes at 
the end of a high temperature phase. All bleeding other than true menstruation is con-
sidered fertile [12]. 
CHAPTER III 
CURRENT OVULATION MONITOR DEVICES 
OVERVIEW 
Fertility Monitors Based on SER and VER Methods 
CUE Fertility Monitor. The CUE Fertility Monitor (Zetek, Inc., Aurora, CO), is a 
battery-operated device with a digital readout that indicates the measured resistance at 
the two sensors one oral (saliva) and one vaginal (vaginal mucus). The measurement 
process requires about 10 seconds. A constant, alternating current source was used to 
minimize polarization effects at the electrodes. Calibration of the device is in arbitrary 
units which are directly proportional to resistance in ohms. A tenfold difference in VER 
and SER prevented a direct ohmic readout in the instrument because it was designed to 
be simple to use. The conductive electrodes of the sensors were stainless steel [16]. 
The results of this study indicate that SER may be used to obtain an indication of 
the beginning of the fertile phase of the cycle by predicting ovulation 5 to 6 days in 
advance, whereas VER enables a more short-term indication and later a confirmation of 
ovulation. Thus, the two methods may be combined to accurately define the fertile phase 
of the menstrual cycle. Albrecht concluded in his studies that this method is a simple but 
reliable tool for the management of infertility and an aid to the practice of NFP [16]. 
Later studies have confirmed the accuracy and usefulness of the CUE monitor for the 
prediction and detection of ovulation [5, 15, 17, 18]. 
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Urinary Hormone-based Kits 
There have been several urinary LH kits developed during the last decade. These 
methods rely on a two-site immunospecific assay in which an enzyme is linked to an 
antibody specific for the beta subunit of LH, which produces a blue color in the presence 
of substrate. The intensity of the color change is proportional to the amount of LH 
present. Results are obtained by detecting a consistent color change using as reference a 
surge guide provided by the kit. Daily sampling is necessary beginning on day 11 of the 
cycle until a sustained thermogenic shift in the BBT is identified [20]. 
In a recent study made by Rodriguez et. al [28], two immunoassay kits Ovustick 
(Monoclonal Antibodies, Inc., Mountain View, CA) and TestPack (Abbott Laboratories, 
Abbott Park, IL) were analyzed. These home-use kits are based on the detection of the 
day of the urinary LH surge. In this study, both devices predicted ovulation in 85% of the 
cases. TestPack provided faster results and was easier to use than the Ovustick. TestPack 
also had another advantage: a first morning urine sample, instead of a midday sample, 
could be utilized. Use of the first morning urine is more convenient for women who 
work outside the home. Because the results were similar with the two tests and use of the 
TestPack was more convenient and easy, Rodriguez suggests that of the two methods of 
detecting ovulation, TestPack appears to be better [28]. 
Other devices based on the principle of detection of urinary LH surge are: 
Discretest (Organon, Oss, The Netherlands), Right Moment (Seragen Diagnostics Inc., 
Indianapolis, IN), and First Response (Tambrands Inc., Palmer, MA). In a study in 1987, 
Vermesh et al [2] demonstrated that First Response predicted ovulation only in 53.3% of 
the cycles, which makes this device an inaccurate predictor of ovulation. 
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Kits Based on Cervical Mucus Properties 
The OvuTest. This device known as "Determine; The OvuTest" (Ventco Medical 
Trading Company, Montreal, Quebec, Canada) was designed to determine the optimal 
time for human conception by detecting the presence of the protein, uteroglobin (UTG), 
in cervical mucus. The device is a vaginal probe, connected by an insulated electric wire 
to a metering unit powered by a 9-volt battery. In indicator needle on the metering unit 
deflects in the appropriate direction when optimal conditions for conception are present. 
The device is described as having the operating principle to measure the electrochemical 
charges resulting from the combined charges of proteins that bind differentially to the 
two metals of the probe's electrodes. This might reflect a variety of changes in ferdlity-
associated compounds. The manufacturer claims that the probe specifically detects the 
protein uteroglobin (UTG; or blastokinin), and that UTG is present in the vagina or cervi-
cal mucus only during the time of ovulation. However, Daniel et. al proved that results 
obtained with the OvuTest were "variable, indeterminant, and erratic, and therefore, use-
less for determining the time of ovulation" [29]. It was also shown in Daniel's studies 
that obtaining the meter reading takes at least 2 minutes, which adds more difficulties to 
this method. 
BBT-based Kits 
The small increase in BBT has spawned a number of technical innovations that 
make its occurrence more obvious: mercury thermometers with expanded scales; elec-
tronic thermometers, some supplemented with the microcircuitry required for data 
storage and computation; and recording charts with vertically expanded scales [4]. Some 
of the most common devices based on the BBT technique are: 
Bioself 110. The Bioself 110 device (Bioself Canada, Inc., Montreal, Quebec, 
Canada) is a hand-held, non-invasive that measures basal body temperature and cycle 
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length, and automatically identifies the fertility and infertility phases of the menstrual 
cycle. This instrument measures BBT orally, vaginally, or rectally in 2 minutes and keeps 
track of the last 64 temperatures and the length of the last six menstrual cycles. A 
microprocessor with a mathematical algorithm identifies the upward shift in BBT that 
follows ovulation, and through the use of light signals, it provides the user with an indi-
cation of her level of fertility: a green light indicates "infertile", a flashing red light indi-
cates "fertile", and a constant red light indicates a transitional stage during which the 
woman is "probably infertile". The memory of the Bioself 110 can be retrieved in a 
graphic form by inserting the device into a special printer, which was also provided by 
Bioself Canada, Inc. [30]. 
L Sophia. This device is based on the basal body temperature and the Ogino 
method. It records the daily temperature automatically and also some other symptoms, 
such as fever, bleeding, etc. The user is able to see a bar graph on a digital screen show-
ing the temperature during the whole cycle. By flashing a series of figures, L Sophia 
indicates the fertility status. 
According to the reference manual, to use L Sophia for birth control, it is absolutely 
necessary to adhere to the following measures, because it is not possible to obtain reli-
able data if you fail to observe even one of the measures; and without this reliable data, 
you cannot carry out birth control securely [27]. 
• Measure the temperature each morning at the time of awakening, while in bed, 
before rising. (Do not rise, do not move about.) 
• Do the measuring at the same time daily. 
• Measure the temperature daily. 
• When the user has a cold or other illness with fever, do not record the temperature. 
Since this is a recent device, no evaluation reports have been published so far. 
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Serum Hormone Assays Products 
These are probable the most reliable and accurate devices currently developed for 
the detection of the day of ovulation. However, they present the inconveniences, such as 
the patient has to make visits to the clinic during many days, and also requires blood 
tests. Examples of some of the companies that manufacture these type of products are: 
(LH, FSH, and P) (Farmos Helsinki, Finland), 
(LH-polyclonal, P) (Diagnostic Products, Los Angeles, CA), 
(LH) (Hi-Gonovis, Mochida Pharmaceutical Co., Tokio, Japan), 
(LH) (Serono Diagnostics, Randolph, MA). 
CHAPTER IV 
CURRENT METHODS AND THE OVULO-COMPUTER 
There is little doubt of the usefulness of fertility monitors. Both physicians and 
infertility patients are demanding simple and reliable devices for monitoring ovulation. 
It has been shown that the goals of the methods mentioned in the previous chapter have 
been similar: to provide an accurate and easy-to-use device that may help doctors and/or 
patients keep track of ovulation timing. It has been evident, however, that not all of these 
methods have been successful. Later studies which have attempted to evaluate and 
confirm the usefulness of any particular method have shown that few of these methods 
fulfill 100% of what they claim, and some of them have even been shown to be contrad-
ictory or highly inaccurate. 
On the other hand, even the most current successful ovulation devices do not pro-
vide an efficient way to keep track of past medical history. As mentioned before, some 
of these kits detect the changes in the ovulation timing by turning lights on and off, by 
changing colors of substances, by the distance a needle indicator deflects or by using 
arbitrary units. That shows that there is a lack of standards of what to measure and how 
to measure it. 
SUGGESTED PARAMETERS TO BE MEASURED 
The purpose of the QC is to integrate a series of useful variables in the prediction 
and detection of ovulation. Because there is no absolute rule as to what should be meas-
ured or how many parameters should be used, the OC system should be flexible enough 
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to enable the user to add new variables to the system whenever possible. Furthermore, it 
has been reported in several studies that in order to reach higher accuracy in predicting 
and detecting the timing of ovulation, it is necessary to combine two or more methods [5, 
11]. 
Keeping track of ovulation timing using methods based on ultrasound or hormone 
assays presents some problems. First, these tests require very specialized equipment and 
therefore, are too expensive. Second, none of these methods predict the day of ovulation 
far enough in advance to be of use as a contraceptive method. Third, it has been reported 
that some of these methods cause discomfort for the patients or take a relatively long 
time, i.e., 5 minutes for ultrasound [2, 6, 11]. Fourth, as reported by Fehring, to achieve 
rates close to 100% certainty in detecting ovulation with some methods, such as urine LH 
self test kits, testing should be done twice a day, which is inconvenient, expensive, and 
time consuming. For these reasons, ultrasound and hormone assay methods are not con-
sidered as potential techniques in our system. 
Methods based on physical or chemical properties of the cervical mucus have been 
reported to be not very promising [21, 29]. Techniques based on physical properties are 
to a certain degree successful; however, they have some inconveniences, for example, 
how to extract the cervical mucus, discomfort for the patients, and more importantly, 
reliability. Considering the chemical properties in the cervical mucus, although many 
parameters change in response to the estrogenic and the ovulatory phase of the cycle, few 
change early enough or in a consistently great enough manner to be useful for ovulatory 
prediction in time to avoid conception. Four days before ovulation is the minimum time 
for sperm in the female reproductive tract to undergo death. To date, no unique consti-
tuent of cervical mucus present as early as that has been identified which could be simply 
and easily determined. Most properties require at least a direct sampling method and a 
simple laboratory as well [21]. Nevertheless, the analysis of some of these chemical 
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parameters could be considered in our system in the future, for the purpose of encourag-
ing the research on the ionic composition not only of cervical mucus, but also of other 
body liquids, such as urine or saliva. 
After analyzing the most recent studies on ovulation monitoring, it has become clear 
that one of the most promising techniques developed so far is the Salivary and Vaginal 
Electrical Resistance Method. This technique has some clear advantages over other 
methods. First, it was shown to be highly reliable. Second, the changes observed in 
electrical resistivity are significant; thus, it does not require extremely sensitive elec-
trodes, and this makes the interpretation of the data easier. Third, the procedure to make 
the measurements is relatively easy and only takes about 10 seconds. Fourth, and most 
important, this is the only method that so far has been demonstrated to provide ovulation 
prediction early enough (>5 days) to be used in natural family planning as a method of 
birth control. It is for these reasons that SER and VER are the most important parameters 
to be measured in our system. 
The Sympto-Thermal Method has been demonstrated to be the most reliable method 
of periodic abstinence [12, 11]. Although this method still presents some difficulties for 
charting and chart interpretation, the OC features will facilitate data gathering and will 
enhance greatly the data interpretation. As part of the STM, BBT changes will be con-
sidered an important variable for the detection of the day of ovulation. Many other 
symptoms will also be added to the OC database which will not take an active role in the 
automatic decision making, but will be available to the user to confirm results and/or to 
base any other type of decisions. The combination of STM with the VER and SER 
methods will likely provide the most reliable and accurate NFP method currently 
developed. 
The first day of the menstrual flow (day 1) will be an important variable, since most 
of the OC methods will need this parameter as a point of reference for later calculations. 
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Finally, the OC will consist of three numerical variables, e.g, BBT, VER, and SER, 
plus many symptoms that also will be recorded. However, as mentioned before, the OC 
will be able to accept new variables at any time, with minimum adjustments to the data-
base. 
CHAPTER V 
WHY A COMPUTER-BASED SYSTEM 
The use of computer-based information management systems has increased rapidly 
in recent years in an effort to adequately process all the patient data being provided by 
advanced medical equipment. Computer management systems now manage administra-
tive and clinical patient data, images, diagnostic notes and other medical data. Assess-
ments on the usefulness of such data management systems have shown that the data 
management burden placed on the medical staff is greatly alleviated. The same studies 
have expressed the favorable acceptance of these computer data management systems by 
the medical community [31]. 
In an effort to enhance medical decision support, assessment resources, and diag-
nosis accuracy concerning the prediction and detection of the ovulation, an extensive 
research of the latest literature was made, looking for accurate and reliable parameters 
that can be electrically measured. Some of these methods have been already used for the 
production of ovulation kits; however, little has been done in an attempt to integrate 
these methods in a patient database system for use in clinics and hospitals. 
There have been very few attempts to build a computer-based system to keep track 
of the ovulation. In 1984, after field-testing a new set of client forms for monitoring NFP 
performance in Zambia and Liberia, Action Familiale decided to implement the same 
forms within its NFP services. However, since Action Familiale recruits about 2,500 new 
clients annually, it was decided that a microcomputer would be used to handle the data 
processing needs of the organization. Using various packages made available, Action 
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Familiale started computerizing its statistical department as well as other spheres of 
activities. Unexpected problems at many levels cropped up and prevented full use of the 
equipment: the electrical supply and equipment and even part of the hardware were not 
up to local standards; new personnel recruited to work on the computer caused irretriev-
able loss of data due to a poor back-up system; there were bugs in the software; the ques-
tionnaires were not filled correctly; some of the questions were even refused by the NFP 
department and thus were not asked of the clients. Finally, it was decided that the ques-
tionnaire and the whole system would be revised at the end of 1986, and a new approach 
adopted [32]. 
In 1981, a group of researchers presented a proposal to Pope John II concerning the 
design of microprocessor-based device for the detection and prediction of the ovulation 
[6]. Although good ideas were presented in this document, little acceptance was given to 
the project. A later study at Portland State University attempted to develop an image pro-
cessing system to keep track of the day of ovulation based on the Ferning test method. 
However, results of such a project are still not clear, and lately researchers are not putting 
emphasis on the Feming approach anymore. 
The main motivation behind the OC stems from the limitations of the traditional 
paper-based charting system used to record menstrual cycle data. Moreover, the current 
gathering of ovulation data requires nursing staff to periodically read the data measured 
through other equipment at the bedside, and maybe even data made available from other 
departments. This tedious procedure is error prone because of the stressful nature of the 
patient care [31]. By interfacing the sensors directly to the electronic monitoring system, 
the OC will automatically and continuously record the patient data, eliminating the bur-
den and errors of the manual procedure. The user will also be able to enter data from the 
keyboard if necessary. That data could be from other department or any external source. 
Review and interpretation of real-time data is improved by displaying it as graphical 
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trends and charts on a high resolution color monitor. 
The development of a computer-based system to help physicians compare and 
evaluate ovulation detection/prediction methods may appeal to practitioners and 
researchers in the fertility field. As mentioned before, the diversity of opinions when 
deciding the accuracy and reliability of rules has been of great concern to physicians and 
patients [9]. Thus, implementing each of the well known rules in a computer system 
would allow the physicians to apply a set of data, for example from a cycle, to different 
rules. In this way, the user would have a series of results from these rules and would be 
able to evaluate the rules more objectively. 
The tendency in recent years has been away from systems that replace the physician 
or the laboratory technician, emphasizing instead systems designed to assist the medical 
specialist in making better decisions. Under this perspective, the QC is considered a tool 
designed to help nurses and doctors make more accurate diagnosis of the fertile and 
infertile times. 
CHAPTER VI 
MEDICAL DECISION-SUPPORT SYSTEMS 
Decision-support systems for various applications are a rapidly growing area. Their 
growth has been made possible by the development of new theoretical approaches and 
the support provided by advances in programming and in computer hardware. A new 
area that has been stimulated by this theoretical progress is modem medicine, an area 
where experts must make decisions in real time under conditions of considerable uncer-
tainty of the observed facts and insufficient formalization of the practical recommenda-
tions of medical science [33]. 
In general terms, Shortliffe defines a computer-based medical decision-support sys-
tem (MDSS) as a computer program designed to help health professionals make clinical 
decisions [34]. Regardless of the underlying computer-science methodology, clinical 
decision-support systems deal with medical data about patients (similar to what would be 
found in a medical record) or with the knowledge of medicine necessary to interpret such 
data. They generally help in determining the nature of a patient's disease state or in for-
mulating a plan for reaching a diagnosis or administering therapy. In a sense, any 
computer-system that deals with clinical data or medical knowledge is intended to pro-
vide decision support [34]. 
Current enhanced opportunities for progress in the field of clinical decision support 
derive from several sources, including the rapid growth of awareness of and interest in 
computers and information-management systems, the growing usefulness of medical 
information systems for helping professionals with other biomedical research and health 
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care problems, and the continuing rapid development of the technological base [34]. 
Only a decade ago, software tools were rarely used by health personnel and were 
viewed with some skepticism. The change in attitudes has been due in large part to three 
influences: (1) the emergence of microcomputers and easy-to-use software, with the con-
comitant demystification of computers and a general sense in society that such machines 
are manageable and useful; (2) the growing distress among health professionals regarding 
the amount of information they need to practice medicine well; and (3) the increasing 
fiscal pressure that encourages the practice of cost-effective medicine, thereby leading 
practitioners to consider carefully the clinical utility and reliability of tests, procedures 
and therapies, especially when they are expensive or risky [34]. 
In order to understand the range of capabilities that computers can provide in assist-
ing with clinical decisions, Shortliffe [34] has classified three types of decision-support 
functions ranging from generalized to specific: 
DECISION-SUPPORT FUNCTIONS 
Tools for Information Management 
These tools provide the data and the knowledge needed by the physician, but they 
generally do not help non-experts apply that information to a particular decision task. 
Interpretation is left to the physician as is the decision about what information is needed 
to resolve the clinical problem. Examples are hospital information systems which pro-
vide facilitated access to patient data needed for clinical decision making, and biblio-
graphic retrieval systems which allow rapid access to pertinent information from the 
current literature. 
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Tools for Focusing Attention 
Such programs are designed to remind the physician of diagnoses or problems that 
might otherwise have been overlooked. They typically use simple logics, displaying fixed 
lists or paragraphs as a standard response to a definite or potential abnormality. Exam-
ples are clinical laboratory systems that flag abnormal values or that provide a list of pos-
sible explanations for those abnormalities and pharmacy systems that alert providers to 
possible drug interaction. 
Tools for Patient-Specific Consultation 
Such programs provide customized assessments or advice based on sets of patient-
specific data. They may follow simple logics, such as algorithms, may be based on sta-
tistical theory and cost analysis, or may use numerical approaches. Some examples of 
this type of systems are Dxplain [35] and QMR which are diagnostic assistants used to 
narrow the range of possibilities for a particular set of data. Not many systems of this 
category have been reported so far. 
Tools for information management are considered "passive" systems. That is, they 
make information more readily available to the physician but they do not provide 
"active" decision support by applying medical knowledge to a specific patient's data, nor 
do they recommend a specific conclusion or course of action. However, there has been 
less success in developing active systems. One strategy used in such systems applies 
predefined rules to the patient's data and alerts providers to conditions that might require 
action. Systems used for focusing attention present a more active involvement in the 
diagnosis process. 
Active systems contain in-depth knowledge about a well-defined subset of medical 
knowledge and require considerable and detailed information about the patient's clinical 
status to provide the computer-generated consultations. According to the three categories 
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mentioned before, the OC could be considered an active system. Although the final deci-
sion will be made by the physician, the OC automatically analyzes data, and reports all 
important results based on the command given. 
According to Barnett, some important criteria should be considered for a differen-
tial diagnosis decision-support system intended for use in routine clinical practice [35]. 
Such systems should: 
• be easy to use by physicians who have little or no computer background; 
• be based on comprehensive medical content; 
• provide correct and accurate interpretations; 
• justify its interpretations; 
• evolve and improve as a result of user criticism and analysis of user sessions; 
• be convenient to access from the physician's office, hospital, or home. 
These features have been carefully considered in the implementation Of the OC 
system. Remote access facilities is not a important priority of this system; therefore, that 
point is not considered in this thesis. 
MDSS Problems 
Some problems found in MDSS include difficulty in accessing and interacting with 
the systems, a limited area of application, a limited ability of the systems to explain and 
justify the interpretations, and less than acceptable quality of the interpretations. Some 
investigators believe that there are major intellectual and technical problems that must be 
solved before there can be truly reliable consulting programs. In particular, it is claimed 
that computer programs must be able to incorporate pathophysiological knowledge and 
causal relationship based on pathophysiological reasoning. 
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KNOWLEDGE-BASED MEDICAL SYSTEMS 
Decision making in medicine is based on two types of knowledge: scientific 
knowledge and empirical knowledge (experience). Scientific knowledge is acquired in 
the process of medical research, whereas experience is phenomenological. Empirical 
knowledge is less formalized, although it plays a dominant role in diagnosis and treat-
ment selection [33]. 
Recognition of the difference between the two types of knowledge is important for 
understanding the advantages and the fundamental limitations of the computerization of 
medical decisions. Let us consider some characteristics of the two types of knowledge. 
Scientific Medical Knowledge 
This is knowledge acquired by medical research. It does not take into account the 
complete data about the patient, touching only on certain aspects of the data. As a result, 
this knowledge is useful only for processing part of the available information. The rea-
son for this is that medical science is concerned, not with the condition of each individual 
patient, but rather with the general regularities of diseases averaged over a certain group 
of patients. Scientific medical knowledge is abstract. It is therefore valid within the 
specific domain of research, and it is inherently limited because of generalization. 
Models based on scientific medical knowledge also have a generalized and limited char-
acter, i.e., they are abstract models. 
Empirical Knowledge 
Knowledge of the second type, conversely, is not acquired in scientific research: it 
is extracted from the actual experience with patients (problems, processes). This empiri-
cal knowledge is accumulated in the course of observation of a large number of patients 
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under a variety of circumstances. The limitation of empirical knowledge is that the sam-
ple of patients observed by the physician may be insufficiently representative of the 
entire population. Then the accumulated empirical knowledge on average does not fit the 
population, and the physician will periodically make mistakes [33]. 
Formalized medical knowledge thus consists of two components: 
• scientific theories incorporated in algorithms and computer models; 
• medical experience stored in data bases and knowledge bases. 
Most of the operating medical decision support systems utilize a combination of the 
two knowledge components. The purely statistical approach combined with mathemati-
cal modeling is an example of using knowledge of the first type, whereas heuristics and 
expert systems mainly rely on knowledge of the second type. 
The methodology of development of medical decision support systems requires 
resolving the following main issues: choice of the application domain for the system 
(medicine), collection of well-documented medical data, choice of a source of knowledge 
acquisition, choice of a decision making strategy or model, choice of parameters for 
optimizing system efficiency evaluation, and choice of system validation methods. 
Of key importance in this list is the choice of decision making strategy or model. A 
number of approaches have been developed for the modeling of medical decisions. 
Some of the main approaches are listed below: 
Statistical Methods 
These methods usually employ the techniques developed for pattern recognition. 
Statistical methods are mostly used in differential diagnosis. An example of the statisti-
cal approach is provided by the use of Bayes' method. If the distribution P(f]D) (where f 
is a symptom) and all the prior probabilities P(D) of the different diseases are known, 
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then the optimal decision model is the Bayes rule. This rule actually assumes availability 
of complete information about symptoms, disease, and their interdependencies. Because 
of the common differences among doctors, this approach would not be appropriate to 
implement in the OC. 
Logic Methods 
Logic decision making uses yes/no decisions, truth tables, or decision trees. 
Theoretically, statistical and logical decision strategies differ in that the statistical 
approach uses the collection of features (the feature vector) only once for discrimination, 
whereas in logic methods the global classification decision is partitioned into a number of 
sequential partial decisions. The problem is essentially decomposed into a number of 
connected subproblems. Logic methods assume the availability of a larger volume of 
empirical knowledge than statistical methods. This knowledge is utilized to construct an 
adequate decomposition of the original problem. The main difficulty in logic decision 
making is to establish a reasonable balance between the structure of the decision tree 
(table) and the content of the partial decisions in the tree nodes (table cells). The main 
difference between logical and statistical methods is that the former are less formalized 
and apparently provide less opportunity for model optimization [33]. 
Heuristics, Medical Expert Systems 
Application of decision making often contains numerous heuristic elements. The 
heuristic approach to decision making has many unexpected diversions and off shoots, 
which depend on the particular disease and the particular patient, as well as on the choice 
of the heuristics. The construction of a structured logic tree in these cases is a fairly 
difficult problem, which has to be solved by artificial intelligence methods. Medical 
expert systems play a leading role in the development of this direction of medical infor-
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matics [33]. 
The basic elements of an expert system are the knowledge base, which contains the 
terminology and knowledge from some field of medicine, mechanisms of inference (deci-
sion making) that use the knowledge base, and a module that explains the expert system 
decisions to the user [33]. 
The OC and Knowledge-based Systems 
Of all the methods mentioned before, the expert system approach better fulfills the 
requirements in the implementation of a fertility monitor. Although complex and some-
times contradictory, there is a vast terminology and knowledge in the fertility assessment 
field. In addition, there are numerous established rules that help the decision ma.king pro-
cess, and that could depend, to some degree, on the same sources of data. The issue con-
cerning the differences among physicians is dealt through the implementation of multiple 
well-accepted rules, but the final decision is left to the user. 
The fertility field undoubtedly contains elements from both scientific and empirical 
knowledge. However, as far as the establishing of rules is concerned, most of these rules 
have been based on empirical knowledge accumulated from past observations. The usual 
procedure is to evaluate large numbers of cycles in order to gather data to evaluate a new 
method or rule. It is therefore expected that there will be a constant, periodical establish-
ment of new rules. Because this field changes so rapidly, the OC has been given 
sufficient flexibility and adaptability to satisfy current and future research and clinical 
needs. 
CHAPTER VIl 
THE OC DATA ACQUISITION SYSTEM 
As a result of the popularity of personal computers more of them are finding their 
way into laboratories and factories in data acquisition applications. Computers have an 
enormous influence on the course of measurement, control analysis, and presentation 
techniques. Computers are also an important tool in the development of data acquisition 
systems; however, they are not able to produce any productive work without having a 
user and real-world interface. Making the most of the microcomputers requires an under-
standing of the computer capabilities, strengths, and limitations. One of these limitations 
is related to the signals that the computer must process. Most real-world signals (tem-
perature, pressure, flow, speed, intensity, position, etc.) cannot be read directly by digital 
computers. These parameters are represented by analog signals distinguished by their 
continuum of levels [36]. Therefore, a translation device is needed to make these signals 
understandable by the computer. 
The OC data acquisition system consists of seven main functions. The Figure 2 
shows a block diagram and the interactions among these different parts. 
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Figure 2. Block diagram of the OC data acquisition system. 
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The Medical Lab represents the real world the OC will be in contact with in our sys-
tem. It is there where nurses and physicians will perform different types of measure-
ments directly on the patient. As mentioned before, the OC will offer three automatic 
options that will collect data directly from the patient, that is, temperature and vaginal 
and oral resistivity. These sensors will be physically connected to the microcomputer via 
the AID converter board. Of course, data can also be entered manually via the keyboard, 
or through an ASCil file written in the same OC's database format. 
The Sensor Signal Conditioning describes the electronics required to convert the 
varying physical properties of sensors into standard high level signals that can be easily 
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converted by standard AID converters. These functions include: amplification, comple-
tion, excitation, filtering, common mode rejection, protection, linearization and cold 
junction compensation. All these functions are assumed to be part of the electronic sen-
sors that the QC will use. These sensors will not be built. Some medical instrumentation 
companies have already built VER and SER instruments, such as the CUE monitor, 
which allow the user to measure both the salivary and vaginal resistivity. Electronic and 
digital thermometers are much more common and their accuracy, speed, and comfort 
have been improved considerable in the last years. 
Isolation guarantees that there is no electrical (galvanic) connection between the 
sensor on one side of the isolation barrier and the measurement system on the other side. 
Isolation can eliminate ground loops and improve safety and reliability of the system. 
Sensor signal conditioning and isolation are recommended to be performed outside of the 
computer chassis, with external modules or panels. 
The Analog to Digital Conversion is the function that accepts continuous (analog) 
voltage signals and converts them to digital bits, bytes or words, so that digital computers 
can read them. 
The User Interface is really the human interface to the computer: graphic display, 
keyboard, mouse, printing capability and software that makes it all easy to use. The user 
interface allows the user to instruct the QC what to do, and at the same time informs the 
user of the results and warnings. Chapters YID and IX will describe in detail all these 
techniques. 
Data Reduction and Analysis involves using the analytical capabilities of a com-
puter to speed up the process of differentiating between good and bad results. This 
includes comparing and adjustment of data to desired values, and converting values to 
engineering units. Data manipulation of all types is done right after the data is received 
by the program. 
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Data Storage is made on hard disk. A backup option could be also implemented to 
save important data on floppy disks every certain period of time (e.g. every week), 
depending on the volume and the importance of the data. 
IMPORTANT AID CONVERSION ISSUES 
An important part of any data acquisition system is its host computer. There are 
two possible ways to interface the data acquisition hardware with the computer, direct 
connection to the computer bus (internal bus) or via a standard communication channel, 
such as RS-232, RS-432, or IEEE-488. Each method has its advantages and disadvan-
tages. For the purpose of this project the internal bus connection provided the best 
choice. Some of these benefits are: computer plug-in boards represent the lowest cost 
alternative and can gather data at the highest speed. These boards typically have low 
point counts and rely on the host computer for each operation. They are used in applica-
tions where the computer is close to the sensors being measured. 
The main advantages of making direct connection to the PC bus include high speed, 
low cost, and smaller size. Cost is reduced with this kind of AID converter system 
because it does not require its own separate enclosure or power supply. Power is 
obtained from the PC. When the data acquisition hardware resides inside the host com-
puter, important advantages in both size and space utilization are obtained. High speed is 
achieved by eliminating the relatively slow, external, communications-channel protocol 
[36]. 
Speed and resolution are the major considerations of the AID converter. The actual 
AID conversion can be performed by one of three common methods: integration, succes-
sive approximation, or parallel (flash) conversion. These methods provide tradeoffs 
between speed and conversion accuracy. For most applications, 12-bit resolution is 
sufficient. This provides voltage steps of 1.22 miliivolts for a 5-volt range and 2.44 
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millivolts for a 10-volt range. A resolution of 16 bits has smaller steps, but require:; more 
time to execute and is more expensive. Eight bits is coarser and less accurate, but it is 
faster. Integrating and successive approximation converters can be used for 8-, 12-, or 
16-bit resolutions [37]. 
Other important issues to be considered in the selection of an AID conver:er are 
related to the input types and to the data transfer methods. First, input channels can be 
single-ended or differential. Single-ended inputs have the same reference potential. Dif-
ferential inputs offer an excellent noise immunity called common mode rejection raiiD 
(CMRR). Differential inputs respond to differences in voltage levels between the two 
signal leads, and can improve the accuracy where long cables, and low-level input ranges 
(<1 V full-scale) are used. For these reasons, it is strongly recommended the use of a 
differential-input AID converter in systems like the OC, in which the sensors may be 
several feet away. 
Second, data transfer methods play an important role when short conversion times 
are required. In this system conversion speed is not a relevant issue, since a va..."iable such 
as temperature takes relatively much more time than a AID converter does. Tnere are 
three main data transfer methods: progrannned 1/0, PIO interrupts, and DMA. The OC 
would work with any of them. The programmed 1/0 AID conveners are cheaper, how-
ever, slower. Interrupt- and DIV1A-based AID converters are faster, relatively more 
difficult to program, and more expensive. 
Finally, another very important part of the OC data acquisition system is the pro-
gram that controls the hardware of the ND converter. The data acquisition program 
communicates with the hardware of the system by using one of the user ports available in 
the microcomputer. One of the most common causes of failure when trying the board is 
address contention. Some of the computer's I/O space is already occupied by internal I/0 
and other peripherals. The ND converter therefore should have several configurable I/O 
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ports in case that some of them are already occupied. This program also is in charge of 
collecting the data read from the AID converter. Then, that data is displayed and/or 
stored in a specific format for later manipulations. 
THE AID CONVERTER USED IN THE OC 
The AID converter board used in the OC was the AD510 multichannel board built 
by Real Devices (State College, PENN). This board can be installed in a single or full-
size expansion slot in the microcomputer. 
The analog-to-digital (AID) circuitry receives up to eight single-ended analog inputs 
and converts these inputs into 12-bit digital data words which can then be read and/or 
transferred to PC memory. The I/O port used for the AID converter was at the starting 
address 200H. However, there is up to eight different starting addresses where to choose, 
which offers great flexibility for those systems that already have some of these ports 
occupied. 
The input voltage range is -5 to +5 volts for a gain of 1 (the range is -0.5 to +0.5 
volts for gain = 10; -0.05 to +0.05 volts for gain = 100). The dual slope integrating AID 
converter performs conversions at a rate of either 7 .5 or 30 Hz, depending on the setting. 
The 7 .5 Hz rate provides high rejection (over 60 dB) of 60 Hz line noise. 
AID conversions are performed by a dual-slope integrating converter. The output is 
a 12-bit data word plus a sign bit which tells you whether the digital value represents a 
positive or a negative voltage. The programmable gains of 1, 10, and 100 let you discern 
changes in the input voltage as small as 13 microvolts. The converted data is read and/or 
transferred to PC memory, one byte at a time, through the PC data bus. 
The converter samples the input voltage over a window of time before performing 
the conversion. The converter measures the time required to charge and discharge a 
49 
capacitor. A counter and a reference in the AID chip determine the integration period. 
Because the input signal is sampled for a specified period instead of being instantane-
ously captured by a sample-and-hold device, spikes and glitches which may be present at 
the input are averaged out. The result is a highly accurate conversion. 
CHAPTER vm 
THE OVULO-COMPUTER SYSTEM 
One of the first questions asked at the beginning of this project was, how to struc-
ture the data, and what programming language or software package to use? As the work 
went on and the main goals were better defined, we realized that the amount of program-
ming would be very extensive, and to create a flexible system with the capacity to evolve 
and be improved as a result of user criticism would require an application package such 
as a spreadsheet. 
To make the decision about what kind of software should be used, the following 
aspects were considered: 
• A specific focus of this project was to develop an application for the microcomputer 
in the field of medicine, rather than software development. 
• There is a vast quantity of powerful programming tools available that could serve 
not only to simplify the work, but also to greatly improve the data management and 
presentation. 
• One of the goals of the project was to exploit as much as possible current micro-
computer capabilities both hardware and software, and therefore, the focus was on 
integrating some of these tools to build up a specific application, a fertility monitor. 
Some of the hardware tools are, for example, the microcomputer itself, the ADC, 
the biosensors (CUE monitor electrodes and electronic thermometers). Examples of 
the software tools applicable to the OC are spreadsheets and high level program-
ming languages. 
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There was an initial attempt to develop some programs from scratch in C language. 
Although some of the results were satisfactory, issues, such as expandability, user inter-
face and others were restrictive and required a substantial amount of work. Based on 
some basic knowledge I had on the 1-2-3 spreadsheet, I decided to try to implement the 
same functions as I did in C language. As a result, it became obvious that the direction 
should be the use of a spreadsheet. 
THE 1-2-3 SPREADSHEET 
Once the decision to use a spreadsheet was made, some of the following aspects 
were considered to decide which one. 1-2-3 is one of the most popular products ever 
introduced for microcomputers. 1-2-3 has three integrated functions: an electronic 
worksheet that manipulates numeric information; a database program that stores and can 
selectively retrieve information; and a graphics program that depicts the numeric data in 
graph form. The manipulating features of 1-2-3 allow data to be displayed in a variety of 
ways, and offer users many opportunities to customize. 
Combining the power of macros and the autoload feature results in a very user-
friendly program that requires, for the most part, only the numeric keypad and ENTER 
key. Data presentation makes use of the versatile features of the 1-2-3 spreadsheet. The 
new 123 3-D features allow the programmer to have up to 256 worksheets in one 
worksheet file. A worksheet consist of 8192 rows and 256 columns. The intersection of a 
row and a column forms a cell. Each cell can contain one numeric data item, text, or a 
formula. The width of each cell can be adjusted so that text or data can be clearly seen. 
1-2-3 Macro Basics and the OVULO-COMPUTER. 
The OC has been totally based on 1-2-3's command language, which is a full pro-
gramming language. Its implementation was based on 1-2-3's built-in functions, 
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keyboard macros, and command language macros. Briefly described, the built-in func-
tions consist of menus and sub-menus which contain over 100 functions grouped in many 
categories for a wide variety of specialized calculations. Some of the most useful 
categories used in the OC were the ones for database, statistical, time and date, 
mathematical, and logical operations. 
Keyboard macros are essentially columns of label entries that have a name assigned 
to them. The contents of the labels are sequences of keystrokes that the programmer 
wants 1-2-3 to execute for him, for example, Page Up, Run, etc. Command language 
macros are powerful functions that allow the programmer to create custom menus, utilize 
iterative loops, and alter the order in which commands are executed in response to entries 
provided by the operator. For more details on 1-2-3 macros refer to the 1-2-3 Reference 
Manual or any recent book on 1-2-3. 
IMPLEMENTED FUNCTIONS 
User Interface 
This was one of the first goals defined at the beginning of the of this project. 
Although many professionals in medicine have shown a great interest in computers, there 
is still a great majority who are reluctant to or scared of computer systems. 
In response to this need of user-friendly systems, the 1-2-3 spreadsheet was chosen. 
By using the 1-2-3's versatile custom menu features, the QC user interface has been 
enhanced considerably. Custom menus allow the user to execute or select any of the QC 
functions by pressing just the arrow keys and Enter. Each time the user starts the QC the 
Main Menu appears in the control panel. The control panel consists of the upper three 
lines on the screen. The user has access to any of OC functions via the control panel. 
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As shown in Figure 3, there are many levels for some of the main functions. For 
better understanding and guidance, a mode indicator has been added in which are shown 
the menu depth and title. This mode indicator is located in the upper right corner of the 
screen. Most of the main functions have help windows to instruct the user of any further 
procedure, or to warn the user of some careful procedures, especially when accessing 
patient files. The whole worksheet section, where the programming code is, has been 
write-protected to avoid any accidental changes. Thus the user is allowed to write or 
modify data only in the database area, which consists of n number of columns, one 
column per variable. 
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fore, customizing the system may be necessary, process which would not require any 
major adjustments to the system. 
Data Visualization 
In this section the main features that provide the versatility of the OC system will be 
discussed. 
One of the main motivations for building a computerized system to keep track of 
the status of the fertile period in a woman's cycle was the inherent need for easy-to-use 
techniques for the visualization of the behavior of the different parameters involved in 
the decision. To achieve this purpose, the OC, using 1-2-3's features, integrates (in its 
primary stage) three numeric daily variables: BBT, SER and VER. In addition, the OC 
has the capability of recording any number of relevant cyclic symptoms helpful in the 
diagnosis of the fertile and infertile days. 
There are two main data presentation styles implemented in the OC. First, data is 
presented in an organized table style allowing the user to look at individual values in the 
corresponding units. All of the variables are recorded in consecutive order according to 
the date when they were entered. The symptoms are also dated and presented in a way 
which makes it easy to visualize and analyze them. 
The other approach in data presentation is in a graphical form. This is probably one 
of the most powerful features of the OC. Values of BBT, SER and VER are displayed in 
x-y line graphs. The x-axis represents the calendar days. The OC displays the y-axis in 
two different scales. Temperature values are plotted based on the left scale of the graph. 
The right scale corresponds to the SER and VER values measured in ohms (Q). The sys-
tem automatically adjusts the minimum and maximum values of these scales based on 
each set of data. The temperature is plotted on a different scale because its range of 
values (normally from 97 .5 to 98.5 °F) is too small compared to the range of VER and 
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SER, which typically ranges from 70 to 180 units. In this way, the user is able to per-
ceive slight changes in the parameter values and therefore, make more accurate measure-
ments. 
The advantage of having the three variables plotted at the same time is essential to 
the improvement in the reliability of the diagnosis. Physicians and nurses are able to 
compare and analyze the variable behaviors to either confirm an obvious result, or to 
detect an abnormality or a special case. As shown in Figure 4, titles, subtitles and com-
ments in the graphs help the user to understand better what is being plotted, as well the 
interpretation of the graph. If a color monitor is used, each of the curves is plotted in a 
different color. If the system has a monochrome monitor, curves are distinguished by 
special symbols that avoid possible confusion or misinterpretation of the data trends. 
Moreover, the addition of legends greatly enhances the graph presentation. Legends 
allow the user to add text to the graph that explains what each range in the graph 
represents. The user might also want to add a grid to the graph to allow a more accurate 
reading of the data values. Both grids and legends are options accessible in the 
Graphics-Options menu. 
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Figure 4. Example of some of the OC graphic features. 
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Another special graph feature that increases the flexibility of this system is the abil-
ity to display the data ranges both in tables and in graphs at the same time. The screen is 
split into two windows; the worksheet data is displayed on the left and the graph is 
displayed on the right. In this special mode, the user can also scroll the data being plot-
ted by just a keystroke. There are also two options to specify how many days to "shift" 
to the right or left of the displayed window, and how many days to display in that graph 
window. Shifting a variable in the graph means to offset the independent variable (e.g., 
days) of the current data range being displayed by a specific value. Moreover, any 
change or addition made to the worksheet data is immediately reflected in the graph on 
the screen. 
58 
Database Structure 
Data in the OC is organized using the versatile organization of the 1-2-3 
spreadsheet. Each single variable was assigned to a column of the worksheet. Columns 
can grow as big as 8192 entries per worksheet. Rows contain the data of each of variables 
for each day. Therefore, the total number of days per worksheet is 8192 (about 22 years 
and 5 months). 
Starting with the day, BBT, VER, and SER values and following with the symp-
toms, the QC can have as many variables (both numeric or text) as desired. Each row of 
the worksheet corresponds to a day of the menstrual cycle and contains all the data 
corresponding to that particular day. The leftmost column of the database corresponds to 
the calendar days. Then, from left to right the following variables and symptoms are 
displayed: TEMPERATURE, VER, SER, MENSES, CERVICAL MUCUS, CERVIX 
SIGNS, INTERMENSTRUAL PAIN, INTERMENSTRUAL BLEEDING, 
BREASTFEEDING, and INTERCOURSE. As mentioned in Chapter ill, these variables 
have been suggested according to recent studies. However, the QC presents great flexi-
bility if the user wants to add new variables or remove any variable that is considered 
irrelevant. 
The main reference variable of the system is the calendar days. However, the data-
base has also an added variable called "MENSES" which is defined as the first day of the 
menstrual cycle. That data is supplied by the patient and must be entered in the 
corresponding calendar day. The first day of the cycle is a very important variable, since 
many of the decisions and algorithms in the QC depend strictly on the cycle days and not 
on the calendar days. When data is entered using the automatic data acquisition 
(described later), the OC will leave space for missing data and allow the user to add the 
data at a later date. 
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Automatic Data Acquisition 
Automatic data acquisition consists of two main parts. As mentioned in Chapter 
VII, data is first acquired directly from the patient by the analog-to-digital converter. 
Then data is transferred to a file. This procedure will be described later. Once the data is 
stored in an ASCII file, the data is acquired by the 1-2-3 worksheet by executing the 
command Input-Data-Automatically. This command automatically inputs and adjusts the 
data into the worksheet format. However, the user will be asked if s/he wants to enter 
each individual value into the database. This is particularly useful when more than one 
measurement is made in the same day. The has the option to keep the previous values or 
to update them. 
Error Checking. Once the data is read from the file, it does not go directly to the 
database. First, the data is checked to see if there is any evident error in the data values, 
e.g., values too high or too small compared to typical values. If an error is detected, the 
OC beeps warning the user of a potential problem in the data acquisition procedure of 
that variable. If one or more of the values read from the sensors is right, the user has the 
option to add only that particular variable and omit the incorrect ones. 
Manual Data Acquisition 
This option gives the user the facility to input data from the keyboard. This data 
may be from historical records kept on ovulation charts or from any other medical 
department. This data acquisition mode is especially useful when the patient, for any 
reason, is not available for the measurements corresponding to that day. Parameters such 
as temperature or any symptom, which are easily kept at home, could be later entered 
into the database. 
Also, data could be entered into the main database if it were recorded in an ASCII 
file under the same format used in the OC database. This format consists of numerical or 
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text values separated by commas. Each line corresponds to one day. The first variable of 
each line is the temperature value, since the OC provides the date. The user needs to 
position the cursor on the day corresponding to the first measurement recorded in the 
ASCII file. This option could be especially useful for hospitals and clinics that want to 
transfer historical records to the OC database. Once the person typing this data knows 
the format, the only requirements would be a standard PC microcomputer and an ASCII 
text editor. 
CHAPTER IX 
DECISIONS AND RULE Ilv1PLEMENTA TION 
The OC, in addition to providing excellent visualization of parameters, also has the 
ability to make decisions that could help nurses and physicians to make a more accurate 
diagnosis of the fertile and infertile days. The OC could be considered an "intelligent" 
system in the sense that it presents knowledge taken from rules widely accepted by prom-
inent gynecologists. 
Because of the nature of the medical field, it is very difficult to find total or even 
partial agreement among doctors as to the methods, procedures or considerations of their 
studies. To alleviate this potential problem, the OC utilizes knowledge from the most 
reliable and accurate methods currently being used or studied. The user is able to apply 
any of those well-known rules to any particular woman's cycle. Also, there is an option 
which considers all the rules together if sufficient data is available. A description of each 
of these rules implemented in the OC is given in the next three sections. 
RULE DEFINITIONS 
BBT Rules 
All the BBT rules implemented in the OC depend on measurements of the tempera-
ture at least from the Day 6 after the onset menstrual flow. For Campbell's rule, tempera-
ture values have to be taken from the fourth day of the menstrual cycle. Missing values 
are interpreted differently by each rule. Taking good temperature measurements from 
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day 6 of the cycle until the ovulation day is detected, is crucial when accurate decisions 
are required. Some of the figures added illustrate the most critical values that have to be 
considered to make accurate decisions. 
WHO's Rule [9]. The World Health Organization's definition of changes in BBT 
indicates that a shift in BBT to the hyperthermic phase of the cycle should occur within a 
period of 48 hours or less. Three consecutive daily BBTs should be a least 0.2 °C higher 
than the average of the previous six daily temperatures [9]. Missing values are inter-
preted as "don't care". However, when more than one value is missing the rule does not 
guarantee an accurate decision. Figure 5 shows the six previous values before ovulation 
happen, and the consecutive high values ("highs") which determine that ovulation just 
happened. 
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Figure 5. Critical values as considered by WHO's BBT rule. 
VERMESH's Rule [2]. BBT has to be measured from the day 5 of the cycle. The 
temperature charts are interpreted with the nadir (lowest point on the temperature curve) 
as the predictor point of ovulation. The BBT nadir is the lowest point on the curve, fol-
lowed by two or more consecutive rises, of which at least one is above the baseline. 
Ovulation will occur in any of the next three days [2]. A missing value around the day of 
ovulation may result in no detection of the ovulation for that particular cycle. An exam-
ple of the type of cycle detected by this rule is shown in Figure 6. 
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Figure 6. Critical values as considered by Vermesh's BBT rule [12]. 
BIOSELF 1 lO's Rule [24]. This algorithm requires eight temperature measurements 
before it can identify the temperature shift from the preovulatory level to the higher level 
which follows ovulation. In a run of eight consecutive temperatures, the last three tem-
peratures are compared with the first three temperatures, skipping the middle two read-
ings. The three higher temperatures, individually and combined, must be higher than the 
three temperatures against which they are being compared by a specified amount. Miss-
ing data may not be as critical as in other rules. However, it may also result in no detec-
tion of the start of the infertile time. 
CAMPBELL's Rule [4]. Algorithms for prospectively interpreting BBT begin by 
establishing a baseline, e.g., the average of the temperature from days 4-11 after the 
beginning of menses. A coverline, or reference line, is drawn 0.05 °C (0.1 °F) above this 
baseline and serves to approximate the upper bound of a confidence interval allowing sta-
tistical comparisons between the baseline mean and the subsequent, daily temperature 
measurements. A rise above the coverline signals the recent occurrence of ovulation and 
allows computation of the end of the fertile period [ 4]. Missing data is not taken into 
consideration. However, if many days are missing the average value obtained may be 
considerably changed. 
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Basic Sympto-Thermal Rule [12]. To fulfill this rule the woman has to chart both 
the temperature and mucus observations. There are several steps: See Figure 7. (1) Set 
the pre-rise base. This is the highest of the final six lows before the thermal shift. (2) 
Determine the peak day. Peak is the last day of any trait of egg-white mucus. (3) Draw a 
"full thermal shift level" line 0.4 °F above the pre-rise base. (4) If the third reading after 
the mucus peak is higher than the full thermal shift level line completely infertile time 
starts that evening. If the third temperature value after the mucus peak is below the full 
thermal shift level line, wait until evening on the fourth high reading before assuming 
completely infertile time. Missing data may vary the pre-rise baseline, but the rule still 
provide a decision. 
High enough to assume CIT on 
the THIRD encircled reading. 
Figure 7. Example of the critical values considered by the Basic STR [12]. 
Temperature-Only Rule [12]. This rule looks for three high values in a row all 0.4 
°F or more above the pre-rise base. The three values have to be consecutive as shown in 
Figure 8. Completely infertile time begins on the evening of the third high value. As in 
the Basic STR, missing data may affect the value of the pre-rise base, but the rule still 
provides a decision. 
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Figure 8. Example of the critical values considered by the Temperature-Only 
rule [12]. 
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Mean temperature Rule [12]. This rule uses the mean (average) temperature of one 
cycle as the dividing line between lows and highs for the following cycle. Therefore, 
daily charting has to be done in order to use that information for the next cycle. Com-
pletely infertile time begins in the morning on the fourth high temperature value in a row. 
Missing data may result in delaying the start of the infertile time. 
QC-Albrecht's Rule [16]. Based on observations in some of the BBT cycles and 
according to some general statements reported by Albrecht [16], a new rule for the esti-
mation of the possible day of ovulation was established. This rule detects the day of ovu-
lation by identifying a shift of 0.2 °F or higher than the average of the previous six daily 
temperatures. Figure 9 illustrates the average line. The Dashed vertical line indicate the 
estimated day of ovulation. Missing data around the day of ovulation may result in 
detecting the possible day of ovulation one day after the day it actually happened. 
Figure 9. Average line and estimated day of ovulation as determined by 
QC-Albrecht's rule (12]. 
VER Rules 
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All VER rules are based on very similar criteria and are illustrated by Figure 10. 
Making good measurement around the day of ovulation is essential for all these rules. A 
missing data around the VER nadir day may result in no detection of ovulation for the 
particular cycle. 
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Figure 10. Typical VER values around the day of ovulation. The black bars 
show the timing of the LH peak (18]. 
ALBRECHT's Rule [16] According to Albrecht's results a clearly defined nadir of 
the VER values was found on the LH peak day. The nadir value constitutes an indepen-
dent value, that is, there is a minimum value (68.5 units) that could be used as a reference 
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value, since the VER values before and after this day are significantly higher. Besides 
this reference value, there is a marked change during a 24-hour interval occurred between 
the VER nadir day and the next day. This rise is about 70% (48 units) higher than the 
VER nadir value. 
FAZLEABAS' Rule [17]. The nadir of VER was defined as the low vaginal reading, 
observed four or more days after the SER peak, and just prior to a sustained significant 
increase [17]. See also Figure 11. 
MORENO's Rule [15]. A vaginal nadir is defined as: a decrease in vaginal readings 
with a subsequent increase for at least 4 consecutive days. Therefore, the vaginal nadir 
cannot be determined until at least four days after it has occurred. The fourth day after 
the nadir has occurred is thus called the VER "signal". In certain cases, the vaginal read-
ings in one of the four consecutive days may not show a continuous rise. A plateau or 
slight decrease may be demonstrated. The vaginal nadir will still be defined by the previ-
ous lowest reading as long as subsequent readings do not approach within 20 units of this 
nadir [15]. 
SER Rules 
Figure 11 illustrated a typical behavior of the SER values in woman's menstrual 
cycles. Making good measurement around the day of ovulation is essential for all these 
rules. A missing data around the SER peak day may result in no prediction of ovulation 
for the particular cycle. 
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Figure 11. SER values around the day of ovulation. The black bars show the 
day of ovulation as estimated by LH analysis [18]. 
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ALBRECHT's Rule [16]. The first peak in SER values from each cycle, occurring 
on or after the fifth day of the menstrual cycle, is defined as stage A. SER peak is defined 
by a gradual increase in SER for several days and then a sharp declined after the peak 
value. Then the SER values stay low for three days after stage A, at which time it is 
approximately 40 units lower than stage A. Beginning on the third day after stage A, 
values increase for several days [16]. 
FAZLEABAS' Rule [17]. The SER peak is defined based on the rule used by 
Moreno with a slightly difference. The SER peak is a high oral reading occUITing on or 
after cycle day 5 and followed by lower readings on the two succeedings days, with a 
cumulative difference from the proposed peak of 12.5% or more [17]. 
MORENO's Rule [15]. The following rules are used to define the oral salivary 
peak: 1) A rise in SER readings with a subsequent drop for at least 2 consecutive days for 
a minimum of 20 units. Therefore, the oral peak cannot be determined until at least two 
days after it has occurred. The second day after the peak has occurred is thus called the 
"Signal". 2) A one-day decrease with a subsequent rebound could also define the peak as 
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long as the decrease is substantial and the rebound does not approach within 10 units of 
the peak [15]. 
Because of the accuracy and type of information provided by the symptoms, none of 
the rules were based on them. Symptoms are important secondary indicators that can 
help physicians confirm results obtained by other methods. They need a special type of 
interpretation which is difficult to code and whose information when added to the diag-
nosis is not very relevant. The symptoms of beginning of menstrual was used to deter-
mine the first day of the cycle. 
All of these rules have been implemented using the set of instructions of the 1-2-3 
Command Language. Instructions such as, if ... then ... , custom menus, and function 
calls were some of the most useful for the implementation of the rules. Each sets of rules 
(e.g. BBT, VER, and SER) has been implemented and organized in menus and sub-
menus. 
CHAPTER X 
PARTIAL EVALUATION OF THE OVULO-COMPUTER 
Testing of the system with real data is undoubtedly one of the most important parts 
of any evaluation. Since there is not enough time to evaluate this system in a hospital or 
clinic setting with real-time data, all the data used was taken from fertility journals. In 
fact, most of the papers from which the rules were taken also proved to be important 
sources of data. 
The BBT method was the most thoroughly tested, due to the existence of more data 
reported for this variable. A clear advantage of the data used was that, in addition to 
BBT values, many other parameters (e.g. LH or urinary assays) were also measured con-
currently. That provided a point of reference against which to compare our results. As 
shown by the average of the days after ovulation in Table 1, some sets of data differed 
from each other. Although each cycle demonstrated a cyclical behavior, many ranges of 
values were found among them. That became a positive aspect of the evaluation, since 
the system was tested by exposure to many different types of real data. 
Table 1 shows a summary of the results obtained after testing each rule for all the 
available cycles. Nineteen cycles were used in the BBT tests. The left column 
corresponds to the source of the data. The source data are represented by the author last 
name, and in some cases, the page number when more than one cycle was taken from 
that author. Also, the reference number is provided. The leftmost columns correspond to 
the results of the rules used to determine the start of the completely infertile time (CIT). 
The right most columns represent the results of the rules used to detect the possible day 
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of ovulation (PDO). 
TABLE I 
TESTING RESULTS FROM EIGHT BBT RULES APPLIED TO THE SAME 
SETS OF DATA 
OVULO COMPUTER TESTING RESULTS 
COMPLETELY INFERTILE TIME RULES RULES FOR DETECITON OF OVULATION 
DATASOURCH BI0-.4S BIO-.S WHO TMP-ONLY BSTR VERM CAMP OC-ALB 
Lauric[26] 2 3 2 3 0 0 
Lauric[26] 2 2 2 3 0 0 
Laurie[26] 3 4 4 0 0 0 
Lauric[26] 4 4 6 6 2 0 0 
Lauric[26] 2 6 2 3 1 0 1 
Albrecht(l6] 2 3 3 4 s 0 0 
HuncgcT[l 2) 2 2 2 2 2 0 0 0 
Huneger[l2) 2 3 3 3 2 0 0 0 --
Huneger[ 12] 1 2 2 2 2 -3 0 0 
Huncgcr[l 21 2 2 2 4 3 0 0 
Huncger[l2] 2 2 2 3 2 0 0 0 
H=p[ 12] 1 2 2 4 2 0 0 
Huncger[l2) 1 1 2 3 0 a l 
McCarthy{9 I 1 2 2 6 0 0 0 
Huneger[l2) 2 2 2 2 2 s 0 0 
Huncger[l2] 2 2 3 3 0 0 
Huneger[l 2] 2 3 3 4 0 0 0 
Huncger[l 2) l I I 2 2 0 0 a 
Huncger[l2] I 1 2 2 ~ 0 0 
Avg II of daya: ~i:rov. l.842 2.389 2.473 3.m 2.222 0.9:1l! a O.IOS 
Cycles dctc=d 19 18 19 18 9 14 I 19 19 
StAndan:l Oovi:ttion 0.744 1.161 1.04S !.193 0.628 2.086 0 0.307 
Evaluation of the rules used to detect the PDQ confirmed the reliability of two of 
the rules implemented. First, a total agreement was found between results obtained with 
Campbell's rule and the results reported by many authors. This rule was able to detect 
the PDQ in 100% of the cycles tested. Because of its consistency and accuracy com-
pared to many studies, Campbell's rule became a reference used to test other irnple-
rnented rules. Second, important results were also obtained by using QC-Albrecht's rule. 
As defined in Chapter IX, this rule proved to be an accurate detector of the PDO. This 
rule correctly detected the PDO in 17 out of 19 cycles tested (90%) and the PDO for the 
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other two cycles was detected a day after Campbell's rule. This rule also detected the 
PDO in all the cycles tested. These two rules provided some of the most relevant results 
in our evaluation of BBT as an ovulation detector. 
Of all the rules implemented, the most unreliable and inaccurate was Vermesh's 
rule. This rule was implemented with the purpose of identifying the PDQ. However, in 
only 14 of the 19 cycles was the day of ovulation detected and only in 8 cycles did it 
indicate the day correctly. These results are in agreement with many studies that have 
shown that a BBT nadir on the day of ovulation is an unusual event [38]. This rule was 
considered one of OC's rules for those cases in which a woman's cycle may present that 
pattern; however, its inaccuracy may considerably restrict its usefulness. 
There were also significant results obtained in the detection of the start of the CIT. 
As a general rule according to some authors, CIT starts in the evening of the day 
detected. One of the most reliable of these rules tested was the BIOSELF rule. There 
were two different approaches taken using this rule. The BI0-0.45 version appears to 
give a better performance than the BI0-0.5 rule. However, as shown in Table 1, the 
J 
average number of days after ovulation is not high enough to assume that CIT has 
started. With a factor of 0.5 or higher between the three lows and three highs being com-
pared, the average number of days after ovulation increases enough to assume CIT has 
occurred, according to the literature. The reason these two BIOSELF versions were 
added to the OC was to provide a variety of choices for the experts. Researchers may be 
able to make this rule more accurate and useful by changing this comparison factor. 
Actually, the user is able to choose any comparison value for this rule, by accessing the 
Decision/Tuning option. However, it is recommended that this value be kept in the range 
between 0.3 and 0.6 °F. 
WHO's rule showed an excellent overall performance. An average of 2.5 (SD=l) 
days after ovulation makes this rule one of the most reliable and precise BBT rules for 
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determining the start of CIT. Only in one of the 19 cycles was CIT detected one day 
after the day of ovulation. 
The Temp-Only rule was the most "conservative" of all the rules. The average 
number of days after ovulation was 3.28 (SD=l.2). This is probably one of the safest of 
all the CIT rules; however, it may probably delay the start of the CIT by one more day of 
abstinence than the other rules. 
The Mean-Temp rule, by definition, has an additional requirement; it uses the 
mean-temperature of the previous cycle. This rule has a drawback. Women must take 
their temperature every day in order to obtain a precise average of previous cycles 
against which comparisons are made. Since complete and consecutive cycles are usually 
not reported in the literature, testing this rule was not possible. 
Probably the most reliable and accurate rule of all the CIT rules is the Basic-STR. 
As shown in Table 1, except in one cycle, the CIT was determined exactly two days after 
the day of ovulation. There is a cost however, which involves making observations not 
only of the temperature, but also of the cervical mucus, either sensation or tissue-paper 
observations. For the purposes of rule implementation, the Basic-STR is very similar to 
WHO's rule; however, the user has to crosscheck by looking at the symptoms which 
indicate that the cervical mucus peak occurred at least three days before the CIT day is 
determined. 
Testing data for VER and SER methods is scarce. As mentioned before, these are 
very recent methods and not many evaluation studies have been done. Fortunately, most 
of the studies published so far confirm the validity and reliability of these methods. 
Because of the simplicity of the rules for the evaluation of SER and VER variables, 
results from testing VER and SER techniques were in total agreement with the literature. 
Five sets of data for VER and four for SER were used. Each of these sets of data 
represented a great number of women's cycles. In all cases, the SER peak and the VER 
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peak were detected. Obviously, a more exhaustive evaluation must be made for these 
methods. Some differences in the data ranges for each cycle are due to the calibration of 
the CUE monitor for each study. However, there was consistency in the relative changes 
in each set of data, which is essential for the OC rule implementation. 
CHAPTER XI 
METHODOLOGY FOR TIIE EVALUATION OF TIIE OC 
PROPOSAL 
The primary purpose of this chapter is to develop an objective methodology for the 
evaluation of the validity of the OC as an accurate fertility monitor, and as a system that 
improves the reliability and effectiveness of some methods for the detection and predic-
tion of the ovulation, by automating many error-prone procedures. 
Two hypotheses are proposed for this study: 
1- The effectiveness of the rules implemented in the OC will be greater than that using 
traditional rule interpretation methods. 
2- The OC will simplify the decision-making process by assisting nurses and physi-
cians with automatic procedures. 
The general structure of the study will consist of an experimental group and a con-
trol group. The control group will act as a reference to compare the OC's performance in 
the experimental group. 
Ideally, independent experiments should be made to prove or disprove each of the 
hypotheses. However, since these two experiments would be so closely related, this 
study attempts to use the same data in a single extended experiment. In order to evaluate 
the first hypothesis, two parameters will be measured in both groups: 
- Accuracy of the decision made, based on a reference method, 
Number of unplanned pregnancies during the study. 
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This study proposes the determination of accuracy using the data of three of OC' s 
variable, BBT, VER and SER as follows: For prediction of the day of ovulation for birth 
control purposes only, the SER variable will be used. To detect the day of ovulation, 
VER and SER will be used. To detect the start of the infertile time, VER and BBT will 
be used. 
A coordinating committee should be selected for the process of evaluation in each 
group. Such committees attempt to add a high degree of impartiality to the study. In the 
experimental group, the committee must work closely with someone who knows the OC 
system well. This committee should be formed of nurses and physicians, and an engineer 
who can assist in technical issues related to the specific details of the OC. The commit-
tee for the control group could be formed of nurses and physicians, although NFP 
instructors and practitioners could also be part of it. Each committee is in charge of 
teaching the correct procedures and instructions to the rest of the staff involved. 
Selection of Participants for Both Groups 
Experience indicates that each of the two groups should contain at least 25 patients 
and be equal in size [39]. The allocation of patients will be randomized to avoid possible 
bias. At the beginning, none of the volunteer women will know which group they will be 
in. Each participant must be notified of possible risks such as unplanned pregnancies. 
Participants should also be informed of the confidentiality of the data and the length of 
the study. In this study, the age range of the patients will be from 19 to 40 years of age. 
The length of the study as reported by many should be a minimum of 14 cycles [2, 17]. 
Procedures and Measurements 
In order to compare each of the decisions for each method in both groups, a reliable 
way to detect the day of ovulation is necessary. The urinary LH concentration as meas-
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ured by the Ovustick kit has proven to be a very reliable way to detect the ovulation day 
[2, 40]. It also has the advantage of not requiring clinic visits, since tests can be made 
easily at home. 
Women should not be influenced by any type of information provided by the Ovus-
tick kit. To avoid that women will not be instructed on how to interpret the data provided 
by this kit A LH surge guide is necessary in order to interpret the data. This guide will 
not be give to the women in the experimental group. Procedures on how to use this kit 
and on the interpretation of the data have been reported in literature [2]. Both the experi-
mental and the control group will use the Ovustick as a reference for the day of ovula-
tion. 
This study will be based on the rules as defined in Chapter IX. Each woman in the 
control group will be given a CUE Monitor for VER and SER measurements and a ther-
mometer for BBT measurements. Procedures for VER and SER have been described 
clearly in the literature [16]. Participants in the control group will be taught how to use 
the sensors and devices, and how to interpret the data. Charts will be given to partici-
pants to record each daily measurement, as well as the decisions made in each cycle. To 
keep data more organized and to avoid possible confusion in data interpretation, each 
BBT, VER, and SER values should be charted on separate charts. Charts should at least 
provide an X-axis scale for each variable and the cycle days on the X-axis. 
The time of the day for each of these measurements must also be standardized. 
According to Albrecht's study, measurements of SER and BBT should be made soon 
after the patient awakens in the morning, before eating or smoking [16]. Albrecht also 
recommends that VER measurements be taken during the late afternoon. Most of these 
rules require data collection starting on day 4 of the cycle. 
In order to extract data for the evaluation of the OC as a helper in the decision-
making process (second hypothesis), each member of the control group will be asked to 
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use the OC for data analysis and decision-making procedures. This procedure will be per-
formed at the end of the study when the experimental group has finish the data collection 
process. Thus, the BBT, VER, and SER measurements already stored in the OC by the 
experimental group will be used again for both groups. The control group committee 
members, therefore, will provide important information for two purposes: 
- For the interpretation of the control group patient's data (part of the first hypothesis) 
- To evaluate the usefulness of the OC (second hypothesis). 
To obtain good statistical significance, the control group committee should have as many 
members as patients in that group. To evaluate this hypothesis some questions have been 
proposed: 
- Is the decision-making process faster using the OC? 
- Is it easier to make conclusions about the status of fertility using the OC? 
- Does the QC help the user interpret data obtained from difficult cycles? 
- Is the QC too difficult to operate? 
- Should the OC's user interface, speed or usefulness be improved? 
Control Group Committee Tasks 
- Teach the control group patients the procedures for using the different types of sensors 
and devices. 
- Teach patients how to collect data and interpret the data based on BBT, VER and SER 
methods. 
- Evaluate the decisions made by the patients, using the reference method (Urinary LH 
peak). 
- Provide information for the evaluation of the second hypothesis. 
- Provide assistance and follow-up to the patients. 
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Tasks of the Experimental Group Committee 
- Standardize all procedures concerning data collection and interpretation. 
- Train each each of the committee staff members of the experimental group. 
- Schedule all patient visits to the hospital or clinic where.measurements are held. 
- Collect and interpret data using the OC. 
- Compare and evaluate decisions made with the QC against the reference method. 
Results and Data Analysis 
At the end of the study each committee should have the BBT, VER, and SER data 
recorded in charts for the control group, and stored in the OC for the experimental group. 
Now each committee must analyze and sort the data. Before making any statistical 
analysis of the data, the committees should review each cycle for each participant and 
determine if each cycle qualifies for the study. Some cycles may be incomplete or may 
represent special cases that should be considered differently. Analysis of the dropout rate 
and the possible reasons is recommended. 
Once all data have been sorted and reviewed, each committee is ready to perform a 
statistical analysis on the data collected. To evaluate the first hypothesis, the experimen-
tal group will be compared with the control group using the following parameters. 
- The accuracy of ovulation detection using VER 
- The accuracy of ovulation detection using SER 
- The accuracy of the detection of the start of the infertile time using VER and BBT 
- The number of unplanned pregnancies. 
To determine the accuracy of the information provided by BBT, VER, and SER, 
decisions made before the actual day of ovulation, as detected by the Ovustick, will be 
represented in negative numbers. Decisions made on the day of ovulation will be 
represented by 0, and decisions after the day of ovulation will be represented by positive 
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numbers. For example, a decision made 5 days before the actual day of ovulation will be 
represented as -5 for statistical analysis purposes. This study recommends using the 
mean and standard deviation of the decision days detected in all the cycles. 
To evaluate the second hypothesis, the percentages of the number of people who 
answer the question will be used. Since each answer has has been scored using a scale of 
1 to 5, it is recommended that the number of answers to each of the five questions be 
averaged. 
Possible Weaknesses 
A very exhaustive evaluation may find some pitfalls in the performance of this sys-
tem. In this section, some of these possible problems that could be found will be men-
tioned, as well as possible solution to them. 
Rule implementation in the OC has been made exactly as the rules have been 
defined by physicians. Most of these rules work as expected in regular ovulatory women, 
as well as for some women with some irregularities in their cycles. However, in some 
special cases a rule may work with some extra criteria provided by the physicians. This 
additional criteria needs to be, first, well defined, and then implemented in the OC. 
If after a comprehensive evaluation, it is proven that the system is useful, but too 
difficult to use by the medical personnel, there are Several possible ways to solve this 
problem: 
- Improve the user interface capabilities. 
- Implement some effective training lessons. 
- Write a more understandable user manual. 
Some physicians may find the OC a not very useful system or may want the OC 
with more features. The OC has been implemented in an environment that is easy to 
expand, not only in the number of ovulation variables, but also in features, such as the 
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type of information provided to the user, or the way results are presented. 
Reliability of the decisions made may be questioned not because the whole system 
is unreliable, but because of one of the variables implemented. Therefore, it is strictly 
necessary to isolate the main source of unreliability, and implement another evaluation 
study for the rest of the system. 
Confusion in the interpretation of the OC's decisions may result as a consequence 
of the way results are displayed. Knowing exactly the way physicians want the results to 
be displayed will help improve the interpretation of decisions in the OC. 
This study may also show that the reference method could be biased because 
patients may be influenced by the information provided by the Ovustick. An alternative 
solution to that problem is to use serum LH analysis or ultrasound as a reference method. 
It would not be very convenient for the patients, because they will need to go to the clinic 
many days a month, but in the experimental group the patients have to make visits to the 
clinic anyway. Moreover, before patients are assigned to one of the groups, they have 
already agreed to the option of making clinic visits. 
Evaluation of Other Possible Features 
There are other functions in the OC that have not been thoroughly evaluated. These 
are two of the most important features that are recommended to be tested in future 
evaluations. 
- Software evaluation. A study has to be developed to find possible "bugs" in the whole 
program. 
- User interface. This system has to be exposed to real life. Issues, such as instructions, 
help menus, and simplicity would be improved if the system is criticized by experts. 
CHAPTER XII 
CONCLUSIONS AND FUTURE RESEARCH 
In this chapter the OC' s main features and contributions will be evaluated. This 
analysis has been made based on individual aspects in which, based on several studies, 
there were major contributions. A summary of some of these benefits is that this system 
provides rule comparison and evaluation, and predicts and detects the possible day day of 
ovulation. Also, this system is knowledge based, has decision-making capabilities, and 
keeps historical records for future analyses. It also combines more than one method for 
the diagnosis, is expandable, and is user-friendly. It is relatively cost-effective, is based 
on simple measurements, and provides the user choices of methods. 
• The ability to compare and/or evaluate methods for the timing of the day of ovula-
tion is probably the greatest achievement of this system. The lack of tools for this 
type of evaluation has been the main motivation in order to look for more objective 
tools. As long as the rules can be represented in an algorithm, the computer will be 
able to evaluate each rule for each single set of data or for many if desired. The 
OC's capabilities for handling data different types of data (e.g. temperature and 
resistance) allows comparison of methods based on different type of variables. To 
compare different type of variables, data has to be taken concurrently for each vari-
able so that the results (e.g. the detection of the day of ovulation) may be compared. 
In that way, comparison of the results may lead to important conclusions concerning 
accuracy and reliability. 
The concept of a computer-based system for evaluation and comparison rules con-
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ceming the ovulation timing is a new concept not implemented by anybody before. 
Although for years it has been evident the need for techniques to evaluate rules [ 4, 
9], nobody has developed a computer-based system for such a purpose. As shown in 
Chapter IX, many important comparison results were obtained. Some of the results 
concerning accuracy, and aproximate number of day after ovulation had already 
been reported in the literature [11, 12, 16]. However, comparative studies as 
obtained by the OC are not usually available. Generally, evaluations of methods to 
detect the ovulation are based on a single reliable variable, such as LH hormone 
analysis. This, however, has led to a great diversity of results, many of them often 
not in agreement. As a result it is expected that a system such as the OC may have 
great acceptance as a more objective tool for comparison and evaluation of different 
methods. 
• This system has also the ability to keep historical records of data taken either 
directly from the patient, or from charts kept in the past. As the amount of data 
grows, the potential ability to make statistical analyses and comparisons from the 
accumulated data will be very valuable and will contribute to important studies. 
This ability has long been desired by NFP researchers, whose data is occasionally 
incomplete because of some lost charts or values not recorded. In addition, the 
difficulties presented in analyzing historical records has discouraged retrospective 
studies in this field [8]. 
• Most of the current instruments or home kits utilized to determine the fertility status 
in women are based on only one method or parameter, e.g., temperature, ultrasound, 
LH assays, etc. This has shown to have inherent limitations, especially in women 
who have frequently irregular cycles. Some of these irregularities usually are 
independent of the method used. For example, irregularities in the temperature 
values may not be detected by the VER or SER techniques. Besides, it has been 
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well accepted by physicians that the combination of two or more methods increases 
greatly the accuracy of the diagnosis [5, 11]. For these reasons, the OC has 
included, in its primary stage, three numeric variables and many symptoms that 
have proven to be accurate indicators of the ovulation conditions. Therefore, a great 
improvement in reliability and accuracy is expected. 
• Most reliable methods currently used to determine the ovulation day are based on 
sophisticated, expensive and complicated techniques. In some of these approaches, 
such as ultrasound or LH serum assays, patients are required to make many con-
secutive visits to the clinic every month. Also, some of these methods have prob-
lems related to comfort and convenience. In response to these issues, the QC has 
based its main parameters on relatively simple and reliable methods which, for the 
most part, do not present the problems mentioned above. 
Let us consider the BBT method. This method has been proven to be one of the 
most popular and easiest methods of keeping track of ovulation. It has also been 
demonstrated that BBT is not an accurate predictor of ovulation; however, its poten-
tial as a reliable detector of ovulation, and therefore, of the luteal phase, has been 
widely accepted. On the other hand, some of the BBT's problems as a birth control 
method, reported by some physicians, are related to the inaccuracy of thermometer 
readings, poor charting techniques, or the difficulty of chart interpretations [9]. It is 
clear that the OC's programmed features eliminate some of these problems, making 
the method easier to interpret and more reliable. As long as the data has been gath-
ered correctly, a process which is also assisted by the OC, human errors in the 
interpretation of the data are greatly reduced. 
Now let us examine the VER and SER technique. This is one of the most recent 
methods developed for the prediction and detection of ovulation. Because of that, 
there is still some lingering doubt about its usefulness. However, many researchers 
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have already published positive evaluations and have considered it to be a very pre-
cise and safe method. The special functions in the OC for the interpretation of these 
two variables simplify the decision making task. 
• As mentioned in Chapter IV, there are many methods and devices used to confirm 
the day of ovulation. However, no devices have been built so far for the prediction 
of the time of ovulation. By using the SER variable measured by the CUE Moni-
tor, the OC will be able to predict the day of ovulation 7 to 5 days in advance. This 
is a unique feature that has not been implemented before in any ovulation device. 
On the other hand, the detection of ovulation has been improved by detecting it by 
more than one method, e.g., BBT, VER, and symptoms. This will greatly assist fer-
tile and subfertile couples who want to maximize the chance of conception when 
pregnancy is desired, or to special treatments, such as donor insemination, where 
ovulation timing is more critical. 
• The OC is a knowledge-based system which has the ability to communicate with 
and guide the user, e.g., a nurse or physician. To do this, the OC has been given 
well accepted rules for decision-making tasks. Unless the user wants to extract 
additional information from the data, no additional calculations are required to 
interpret data or make a decision. For the cases in which the decision is not that 
evident, the OC assists the user by providing results from different rules applied to 
the same set of data, which will hopefully narrow down the ambiguities in the deci-
sion. Also, it has been proven that there are many different patterns of cycle 
behavior even among normally ovulating women. By having more than one rule for 
each parameter measured, physicians will have wider perceptions of the changes in 
specific situations, especially in some of those cycles where ovulation could be 
detected by only one rule. 
• Expandability has been one of the main concerns since the beginning of the 
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development of this system. As defined before, the OC system bases its results 
mainly on three numeric variables, primarily because current studies have given 
them much credibility. However, if one or more new variables were to be added, 
minimum changes to the database would be required. It is common to see how 
some methods become obsolete or are no longer emphasized by gynecologists or 
other medical researchers. Indeed, the medical field keeps changing emphasis very 
rapidly. Therefore, the success of any medical system depends greatly on its adap-
tability and ease of modification so that any new variable, method, or variable 
extension may be added at any time without major changes to the system. This 
principle has been carefully considered since the beginning of this project. From 
this perspective, the OC has great potential as an ovulation monitor, since it presents 
a general database structure which is able to be increased to handle as many vari-
ables as desired. 
Expandability in the QC is provided by both software and hardware. From the point 
of view of the hardware, the system already contains 5 extra analog inputs. Some 
modifications to the program that controls the ADC will need to be made. From the 
point of view of the software, 1-2-3 offers many possibilities for growth and 
modification of the database structure. The only changes or additions needed are 
concerned with rule implementation, which in this case is well assisted by the 1-2-3 
command language. Some of these changes could be made by somebody who has 
some knowledge of the 1-2-3 spreadsheet. Other aspects of the system such as the 
database, data manipulation and the user interface techniques will remain the same. 
• File storage and retrieval is undoubtedly one of the most important functions, espe-
cially when valuable data is being handled. These two functions have been care-
fully implemented to guarantee that mistakes made while saving data will not affect 
data already saved in the system. If the data has not been saved, there are some 
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reminders that warn the user. Retrieval is direct and simple. Another aspect of data 
storage is the advantage of having separate files for each patient. This will help 
organize and maintain the data. 
• From the point of view of the patient, there are also some useful features in the OC. 
First, the system is flexible, allowing more than one choice for those patients who 
may not wish to use one particular method. Second, not only does the patient obtain 
immediate benefits by knowing her fertility status, but also she automatically starts 
accumulating data that could be extremely useful for future studies about any partic-
ular abnormality in her fertile life. This type of benefit is very difficult to obtain 
based on traditional charting methods. 
• Although physicians or nurses will make the final decision about fertility conditions 
in the patient, the automatic diagnosis features included in the OC will be well 
appreciated by them. The time they will spend in making a regular diagnosis should 
be much less than that using traditional methods. This should improve the 
efficiency of the personnel. For some specific studies in which doctors may need to 
review historical records about the patient, the OC could also save a great amount of 
time. 
• Cost and maintenance of the system is another attractive feature of the OC. The 
whole system is based on standard hardware and software. The use of a 286, 386 or 
486 compatible microcomputer provides different options to clinics or hospitals, 
depending on the number of patients and the allotted budget. The fact that 1-2-3 is 
one of the most commonly available spreadsheets for personal computers reduces 
the cost of software for those hospitals or clinics that have already bought it. In 
addition, the fact that this system is built based on an IBM-compatible microcom-
puter, support will be available to take advantage of potential improvements based 
on faster and more powerful microcomputers. The analog-to-digital converter 
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selection is less flexible, in the sense that there are no standards stipulated for 
ADC's. ADC's also depend on each individual need. They could be 8 or 12 or 16-
bit resolution, have from 1 to 16 or more analog inputs, and have a variety of 
conversion times. Our system recommends at least a 4-input, 12-bit ADC, whose 
conversion time is less than 100 msec/channel. 
• Using 1-2-3 as the main spreadsheet presents also many advantages. First, 1-2-3 
has guaranteed compatibility with previous releases since its Release l.A in 1982. 
Although the OC only runs under Release 3.1, future releases will also guarantee 
compatibility with the Release 3.1. Second, there has lately been a growing interest 
in spreadsheet applications among professionals in the field of medicine. Physicians 
or nurses with some knowledge of 1-2-3 could exploit many more spreadsheet func-
tions that were not included in the OC macros. 
• Another important goal from the beginning of this project was the design of a user-
friendly system. 1-2-3's custom menus are perhaps the most useful functions to 
create easy-to-use interactive programs. For the most part, mouse buttons, or alter-
natively the arrow and enter keys, are all that the user needs to execute the com-
mands. On-line help is provided for each menu level. Critical feedback from medi-
cal experts concerning improvements in user interface features is also necessary. If 
such modifications are required, a Windows environment (e.g., MS-Windows 3) 
might be useful. That would greatly enhance the user interface, allowing more 
visual features and on-line help menus. 
• Although the original goals were fulfilled, this system is still in its beginning stages 
and some future research and improvements are necessary. First, the system should 
be exposed to medical practitioners in this field and the feedback obtained from 
these experts used to optimize the system. Second, the system needs to be given 
more medical terms. So far, the QC may have many of terms which make no sense 
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to a physician, or that may be interpreted wrongly, but this requires expertise in the 
medical field, which is outside the scope of this project. Third, in conjunction with 
the two aspects mentioned above, this system needs to be tested more thoroughly, 
with data from large numbers of different women. The test done so far has been 
theoretical in nature, although taken from very reliable sources, but the OC needs to 
be evaluated in a wider variety of special cases. Some of these improvements to the 
system can be made by the user himself, since most of the rules can be partially 
modified or tuned up by using the proper commands explained in the user manual. 
Physicians may also suggest the addition or modification of some of the rules. Not 
all physicians agree as to the most reliable and accurate methods to be used, and 
therefore, the OC has been given great flexibility which will allow this system to be 
individualized by the researchers using it. 
• Obviously, the interface hardware between the ND converter and the electrical 
leads of the sensors needs to be implemented. This hardware is strictly dependent 
on the type and brand of sensors selected. Therefore, the first step is to purchase the 
sensor and their technical information, and then adapt them to the ND converter. 
Some of the signal conditioning could be done both by hardware or by software. 
For example, linearlization or scaling could be done by a program. 
• Finally, the system as developed has a solid base on which to continue to build more 
complex features. It automates data management, provides data display, collection, 
manipulation, storage, and graphic depiction. This system has been developed for 
the medical field, since there is an obvious need for such a system. Theoretical con-
cepts from the decision-medical support systems have been used in its implementa-
tion. Concepts about monitoring electrical signals or keeping track of industrial 
processes have also been implicitly used in this system. The use of standard, rela-
tively inexpensive hardware and software tools, many of which may be already be 
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owned by most companies and institutions, may encourage more research into 
stand-along systems with data visualization, and decision-making capacity in non-
traditional systems of our society. 
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GLOSSARY 
Abstinence: Refraining from sexual intercourse. 
Amenorrhea: Prolonged absence or suppression of menstruation. This state is normal 
before puberty, after menopause, and during pregnancy and lactation. 
Anovulatory: Without ovulation (a cycle without ovulation is anovulatory). 
Antibody: An immunoglobulin molecule having a specific amino acid sequency by vir-
tue of which it interacts only with the antigen that induced its synthesis in lymphoid 
tissue, or with antigen closely related to it 
Antrum: The dilated portion of the pyloric part of the stomach, between the body of the 
stomach and the pyloric canal. 
Artificial insemination: Introduction of semen into the uterus or oviduct by other than 
natural means. 
Basal Body Temperature (BBT): The temperature of the body at rest, unaffected by 
activity; taken upon waking ("waking temperature"). 
Basal Body Temperature Method: (BBT) A method of contraception that uses daily 
temperature readings taken immediately after waking to identify the time of ovula-
tion; approximately 24 hours after ovulation the BBT increases. 
Biological Assay: Bioassay. Determination of the amount of a particular constituent of a 
mixture. 
Biphasic: Two different phases, as in biphasic basal body temperature which shows a 
rise in temperature in the second half of the cycle suggestion ovulation has 
occurred. 
Cervical Mucus: A mucous fluid secreted by crypts in the cervix. 
Cervix: The lower, narrow part of the uterus-it opens at birth to provide a birth canal, 
and has mucus-producing "crypte". 
Conception: Generally the beginning of pregnancy. Conception is usually equated with 
the fertilization of the ovum by the sperm but is sometimes equated with the 
implantation of the fertilized ovum in the uterine lining. 
Contraception: Interference with reproductive physiology or with the act of sexual inter-
course in order to prevent conception. "Contraception" is to be distinguished from 
"Natural Family Planning" (which relies on natural fertility awareness and periodic 
abstinence when avoiding pregnancy) and from "Abortion" (destroying human life 
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after conception to prevent birth). 
Corpus Luteum: A gland which for 10-14 days after ovulation secretes the hormone pro-
gesterone. This gland is the remainder of the follicle (housing) from which the egg 
was released at ovulation, and it is yellow in color; hence, the name "corpus 
luteum" (latin for "yellow body"). 
Egg: An ovum; a female gamete; an oocyte; a female reproductive cell at any stage 
before fertilization. 
Enzyme: A protein capable of accelerating or producing by catalytic action some change 
in a substrate for which it is of ten specific. 
Estrogen: A female hormone partly responsible for cyclic changes in the female repro-
ductive system (unopposed estrogen causes the cervix to secrete mucus). It is also 
responsible for secondary sex characteristics in the woman. 
Fallopian Tube: A tube, with a trumpet-like end, to receive and conduct the egg from 
either ovary to the uterus. 
Fertile: Capable of conceiving a child. 
Fertility Rate: (also referred to as the general fertility rate) The number of live births per 
1000 women aged 15 to 44 years in a given year. 
Follicle: Any one of thousands of tiny containers each holding an ovum (egg). Upon 
releasing its ovum it becomes a gland called the "corpus Luteum". One type of fol-
licle is an ovarian follicle which is a very small sac in the ovary in which an ovum 
matures and from which the egg is released. 
FSH: Abbreviation for "Follicle Stimulating Hormone," released by the pituitary gland 
in the brain to stimulate maturation of follicles in the ovary. 
Glucose: In certain foodstufs, especially fruit, and in normal blood, the chief source of 
energy for living organisms. 
Hypothalamus: Part of the brain just above the pituitary which helps regulate basic func-
tions such as sleep, appetite, body temperature, fertility. The hypothalamus in 
influenced by higher cortical levels of the brain and controls hormone production by 
the pituitary. 
Hormone: A chemical substance produced in the body which has a specific regulatory 
effect on the activity of certain cells or a certain organ or organs. 
Implantation: The process by which a newly conceived human being at the blastocyst 
stage imbeds itself in the lining of the uterus about 6-8 days after conception. 
Immunoassay: The measurement of antigen-antibody interaction, as by 
immunofiuorescent techniques, radioimmunoassay, etc. 
In vitro fertilization: A procedure in which an egg is removed from a ripe follicle and fer-
tilized by a sperm cell outside the human body. The fertilized egg is allowed to 
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divide in a protected environment for about two days and then is inserted back into 
the uterus of the woman. 
Infertility: The inability in a woman to conceive or in a man to fertilize an egg. 
Lactation: Producing and yielding milk from the mammary glands (the breasts). Lacta-
tion can produce anovulation. 
Leuocyte: White cell; a colorless blood corpuscle capable of ameboid movement, whose 
chief function is to protect the body against microorganisms causing disease. 
LH: Abbreviation for "Luteinizing Hormone," released by the pituitary gland in the 
brain to trigger ovulation. 
Luteal Phase: The time (normally 10-14 days) of significant progesterone secretion from 
the luteinized follicle or post-ovulatory corpus luteum before menses. 
Menarche: The first menstruation (may occur before of after the first ovulation). 
Menopause: The permanent cessation of menstruation and ovarian activity. 
Menses (Menstruation): A blood and mucus discharge consisting of the sloughed-off 
outer layers of the uterus's inner lining (see "True Menstruation"). 
Monoclonal: Derived from a single cell; pertaining to a single clone. 
Mucin: A mucopolysaccharide or glycoprotein, the chief constituent of mucus. 
OS ("os", Latin for "mouth"): The opening, or "mouth" of the cervix. 
Ovary: The almond-shaped female reproductive organ containing the ova (eggs). 
Ovulation: The process by which an ovum (egg) is released from its follicle (housing) 
through the wall of the ovary, making a woman temporarity fertile. 
Ovulation Method ("OM"): The "Ovulation Method" of NFP developed by Drs. John 
and Lyn Billings of Australia to determine times of infertility and possible and 
probably fertility by exclusive reliance upon sensed and/or seen vulval manifesta-
tions of the absence, presence, traits, and changing or unchanging character of vagi-
nal discharge, particularly of cervical mucus. The World Organization of the Ovu-
lation Method/Billings (WOOMB) was begun in 1977 to promote fertility aware-
ness and family life through natural family planning according to the Billings 
Method. Dr. Thomas W. Hilgers developed the Creighton Model of OM education 
based on the tissue-paper exam. 
Ovum (plural "ova"): The woman's egg. 
Peak Day: The final day of any sign of any trait of the "Most Fertile Sign" during a pos-
sibly fertile time. During a typical mucus pattern the most fertile sign is EW-M; 
during a patch, M; during spotting, any bleeding; and during a prolonged discharge, 
any "difference" that may appear in the discharge. After each such "peak" fertility 
is assumed for the next fol..lr days (until evening of the fourth), in case ovulation was 
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associated with it. If there is more than one peak in a cycle, the peak accompanied 
by a sustained temperature rise is considered the presumptively ovulatory peak of 
the cycle. 
Pearl index: The number of pregnancies per 100 100 per year (100 woman-years) expo-
sure, usually used as a measure of contraceptive failure. 
Periodic Abstinence Methods: Contraceptive methods that rely on timing of intercourse 
to avoid the ovulatory phase of a woman's menstrual cycle; also called fertility 
awareness or natural family planning. 1. The basal body temperature (BBT) method 
uses daily temperature readings to identify the time of ovulation. 2. In the ovulation 
of Billings method, women identify the relationships of changes in cervical mucus 
to fertile and infertile days. 3. The symptothermal method charts changes in tem-
perature, cervical mucus and other symptoms of ovulation (i.e., intermenstrual 
pain). 
Pituitary: Pituitary gland. 
Post-ovulatory: The time of the cycle during which ovulation can no longer occur. 
Pre-menopause: The time (usually the final 60 cycles or so) before menopause, during 
which the menstrual cycle pattern may change to reflect irregular, decreasing fertil-
ity by greater variation in cycle lengths, altered menstrual and cervical mucus pat-
terns, fewer thermal shifts, and shorter luteal phases.' 
Pre-ovulatory: The time during the cycle prior to the occurrence of ovulation. 
Pre-rise Base: The highest undisturbed temperature of the final six "low" readings before 
the "thermal shift" (temperature rise). The amount of "rise" is measured from the 
pre-rise base. 
Progesterone: A female hormone secreted during the luteal phase to prevent further ovu-
lation while enriching the uterine lining for possible implantation. it also causes the 
basal body temperature to rise and the cervical mucus to dry up. 
Progestins: A large group of synthetic drugs that have a progesterone-like effect on the 
uterus. 
Radioimmunoassay: Immunoassay using a radioactive-labeled substance that reacts with 
the substance under test. 
Rhythm Method (Calendar Rhythm): A system of calculating the times of fertility and 
infertility in the present cycle on the basis of the length of previous cycles and cer-
tain assumptions about the time of ovulation and sperm survival. Rhythm was 
based on the independent but simultaneous discoveries of Ogino in Japan and Knaus 
in Austria in the late 1920's, that the post-ovulatory phase of the cycle is "constant" 
in length. It was gradually superseded by discoveries of specific hormonally-based 
signs of the possibly fertile time (the temperature, mucus, cervix, and secondary 
signs). 
Serum: The clear portion of any liquid separated from its more solid elements. 
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Semen The thick, whitish fluid which normally contains sperm and seminal secretions 
and is ejected during ejaculation. It causes conception when it unites with a 
woman's egg. 
Spermatozoon: A mature male germ cell, the specific output of the testes, which impreg-
nates the ovum in sexual reproduction. 
Spinnbarkeit: A test to determine cervical mucus viscosity. A thread of cervical mucus is 
stretched between two glass slides and its length is measured. The time at which it 
can be drawn to maximum length (lowest viscosity) usually precedes or coincides 
with the time of ovulation. 
Sympto-Thermal Method (STM): Any natural family planning system making use of all 
the signs of fertility: basal body temperature, cervical changes, cervical mucus, and 
various secondary signs. 
Symptom: Subjective evidence of disease or the condition of the patient. 
Thermal Shift: The change in basal body temperature level from early cycle lows to late 
cycle highs. The World Health Organization (WHO) considers the shift to be 
"significant" for defining infertility after ovulation when the temperature rises 
within two days to "full thermal shift level" (0.36 °F or more above the highest of 
the final 6 lows) and stays there for three full days. The Sympto-Thermal Method 
requires crosschecking the temperature with cervix and/or mucus signs before 
assuming infertility, but because of the crosscheck, does not require such a pro-
nounced temperature rise to evaluate the temperature pattern. 
True Menstruation: Bleeding is only called "true" menstruation, for use with the 6-Day 
Rule, if the Basic Sympto-Thermal Rule was fulfilled prior to the onset of the bleed-
ing. 
Ultrasound: Sound echo images of soft internal structures. Also called ultrasonography, 
can be used to determine size and position of the fetus, the placenta, a developing 
follicle, or a tumor. 
Uterus: The womb, in which the baby grows during pregnancy. 
Vagina: The soft muscular tract into which the man's penis fits during intercourse. The 
vagina connects the cervix with the vulva and is a birth canal. 
Vulva: The outer parts of the female sex organs, including the vaginal lips (labia). 
